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Mother-to-child transmission (MTCT) of HIV accounts for more than 90% of
pediatric infections worldwide, yet the mechanism of vertical transfer remains unknown.
The feline immunodeficiency virus (FIV)-infected cat is a cost-effective, small-animal
model of HIV pathogenesis and MTCT, which produces a high rate of reproductive
failure and fetal infection in litters delivered at early- and late-term gestation. Our
previous data suggest that FIV infection may dysregulate placental cytokines and
compromise pregnancy. We hypothesized that FIV-infection may cause dysregulation of
placental cytokine expression, and aberrant expression of these cytokines may potentiate
inflammation and transplacental infections. The purpose of this project was to evaluate
feline placental immunopathology at the whole and cellular levels during early- and lateterm gestation to understand how lentiviruses may perturb placental immune parameters.
To determine whether placentas were vulnerable to FIV infection, we quantified the

expression of the FIV receptors, CD134 and CXCR4, in RNA extracted from late-term
placental tissue. We found higher expression of CD134 and CXCR4 in placentas from
successful pregnancies. To evaluate relative cytokine expression in randomly-sampled,
whole placental specimens, we quantified representative pro- and anti-inflammatory
cytokines and a chemokine. IL-6 and IL-12p35 were increased in early-gestation, FIVinfected queens; IL-6 was increased in late-gestation, FIV-infected queens. To evaluate
placental immunopathology at the cellular level, we developed a novel
immunohistochemistry method to identify trophoblastic cells selectively. Trophoblasts
were collected using laser capture microdissection, and RNA was extracted from
captured cells. We detected expression of several anti- and pro-inflammatory cytokines
and the chemokine receptor CXCR4 (the FIV co-receptor) in trophoblasts at both stages
of gestation. However, we failed to detect expression of other cytokines and CD134, the
FIV primary receptor. FIV infection slightly lowered expression of all cytokines at both
early and late pregnancy, although only the decrease in IL-5, from early pregnancy, and
IL-4 and IL-12p35, from late pregnancy, reached significant levels. Fetal non-viability
was associated with decreased trophoblast expression of IL-4, IL-6, IL-12p35, and
CXCR4 at early gestation and decreased expression of IL-4, IL-12p35, IL-12p40 at late
gestation. Collectively, these data indicate that FIV infection negatively impacts
pregnancy outcome and alters placental immunomodulation.
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CHAPTER I
REVIEW OF PERTINENT LITERATURE

The AIDS pandemic remains a global health concern despite prevention strategies
and effective antiretroviral drugs. In 2008, there were an estimated 33.4 million people
living with HIV, 15.7 million of which were women (UNAIDS/WHO, 2009a). Of the
HIV-infected, pregnant women living in low to middle income countries, less than 45%
received anti-viral therapy. Thirty-two percent of infants born to infected, untreated
women received antiviral treatment (UNAIDS/WHO, 2009a). In 2008, children
accounted for 430,000 new infections with HIV and most were the result of mother-tochild transmission (MTCT) (WHO, 2009). In the United States, MTCT is the most
common source of all AIDS cases in children and results in 100–200 infected infants
annually (CDC, 2007). Children who are infected in utero have a more rapid progression
to AIDS and generally become symptomatic during the first year of life. In the absence
of treatment, 50% of HIV-infected newborns will succumb to the disease before 24
months of age (UNAIDS/WHO, 2009b). Fortunately, the use of antiviral drugs by HIVinfected, pregnant women in the United States has reduced the number of perinatally
acquired HIV infections by approximately 90% since 1990 (CDC, 2010). Moreover, the
estimated number of pediatric AIDS cases (defined as AIDS occurring in children under
the age of 13 years) has decreased 64% from 2002 to 2006 in the U.S. (CDC, 2006).
1

However in non-industrialized nations access to antiretroviral treatment is limited, and
without therapy pregnant women are more likely to transmit the virus to their babies.

The Feline Immunodeficiency Virus (FIV)-infected Cat
as a Model for HIV-infections

Discovery of the FIV-infected cat research model
The feline immunodeficiency virus is a lentivirus affecting domestic cats that
causes a clinical course of infection similar to that of HIV. There is evidence of
seroreactivity to FIV in cat sera dating as far back as 1968 (Shelton et al., 1990). The
virus was first isolated in 1986 from cats with clinical features of an AIDS-like complex
in a cattery in California (Pedersen et al., 1987). In 1987, the laboratory of Neils
Pederson first described the feline immunodeficiency virus (Pedersen et al., 1987). The
clinical description of this virus led Pederson and coworkers to realize the potential for
FIV to serve as a model for HIV. Since then, the FIV-infected cat has become the most
utilized small animal model for HIV biomedical research, allowing the study of lentivirus
biology including viral transmission and pathogenesis, host immune responses, and
vaccine development (Willett et al., 1997). Moreover, the FIV-infected cat is the only
animal model for HIV that utilizes a lentivirus that infects its natural host.

Cellular receptors used by FIV and HIV
FIV and HIV are T-lymphotropic lentiviruses in the Retroviridae family. FIV
causes a natural infection of domestic cats that resembles HIV-1 infection in pathogenesis
2

and disease progression. Both HIV and FIV are characterized by progressive depletion of
the CD4+ T cell population and fatal opportunistic infections. Although both viruses use
the same co-receptor, the chemokine receptor CXCR4, FIV does not utilize the HIV
primary receptor, CD4 (de Parseval et al., 2004a; Shimojima et al., 2004). The primary
FIV receptor is CD134 (OX40), a T cell activation and co-stimulatory molecule
(Shimojima et al., 2004). The virus binds these receptors via its surface glycoprotein,
gp95 (de Parseval and Elder, 2001). The cellular tropism of FIV broadens with disease
progression, consistent with the expression of CD134 (Shimojima et al., 2004), and
includes helper T cells, regulatory T cells, B cells, and others. Progression to disease in
HIV-1 infections is correlated with the ability to bind CXCR4 (Connor et al., 1997; Lu et
al., 1997). Similarly, susceptibility to infection with FIV is directly related to cellular
expression of CXCR4, levels of which were shown to be the limiting factor in productive
infection of feline cells (de Parseval et al., 2004b; Willett et al., 2002). Despite the use
of different primary receptors, the shared usage of CXCR4 as a cellular co-receptor by
HIV and FIV establishes similarities in cell tropism between the two lentiviruses, thus
reiterating the usefulness of the FIV-infected cat model.

Modes of FIV transmission
FIV is primarily transmitted via contact with infectious saliva in bite wounds
(Pedersen et al., 1987). Mucosal transmission of either cell-free or cell-associated virus
can be established following application to vaginal and rectal tissue under experimental
conditions (Bishop et al., 1996; Burkhard et al., 1997). Virus was detected in semen
during acute FIV infection (Jordan et al., 1999). Horizontal transmission of FIV was
3

demonstrated when FIV-negative queens became infected after artificial insemination
with semen from asymptomatic, chronically-infected toms (Jordan et al., 1998). There is
no evidence of transplacental transfer of FIV occurring in natural infection (Callanan et
al., 1991; Ueland and Nesse, 1992). However, vertical transmission of FIV can be
readily achieved under experimental conditions with certain FIV isolates (Allison and
Hoover, 2003; Boudreaux et al., 2009; O'Neil et al., 1995; O'Neil et al., 1996; Rogers and
Hoover, 1998, 2002; Weaver et al., 2005).

Feline vs. Human Placentation
The placenta, an endocrine organ of fetal origin, is responsible for metabolic
exchange between the mother and the developing fetus, and produces hormones that are
responsible for pregnancy maintenance and fetal growth. Placentation varies between
species and is classified based upon distribution of chorionic villi and the quantity of
placental layers that separate maternal and fetal blood. Humans, primates, and rodents
have a hemochorial placenta in which the chorionic epithelium is directly apposed to
maternal pools of blood. Therefore, maternal blood products (nutrients, gases, and
possibly viruses) move through three tissue layers and enter the fetal circulation via
chorionic capillaries. Cats possess an endotheliochorial placenta in which the
endometrial epithelium and the underlying interstitium are completely eroded. Thus,
maternal blood products are exchanged through five tissue layers to reach the fetal
circulation via chorionic capillaries. In addition, human and feline placentation also
differs in the distribution of chorionic villi, the functional portion of the fetal placenta.
Humans possess a discoid placenta in which the chorionic villi are arranged on
4

contiguous discs that border the endometrium and provide a site for nutrient and waste
exchange. Cats have a zonary placenta which consists of three zones; a transfer zone, a
pigmented zone, and a nonvascular zone, the allantochorion. The transfer zone is the site
for nutrient and waste exchange and forms around the conceptus. The pigmented zone is
located on the ends of the transfer zone and contains maternal blood clots and
hemorrhages. The allantochorion is a poorly vascularized, transparent zone located on
the chorion distal end and functions in the adsorption of materials from the uterine lumen.
Placental chorionic villi are composed of trophoblastic cells (cytotrophoblasts and
syncytiotrophoblasts). These trophoblasts are fetal-derived cells of epithelial origin that
cover the blastocyst and form the chorion. Syncytiotrophoblasts comprise the outer layer
of the trophoblast that contact and form attachment with the maternal endometrium
(Senger, 2003). The cytotrophoblasts form the inner layer of the trophoblast between the
syncytiotrophoblasts and the chorionic villous capillaries. In human pregnancy, these
trophoblast layers form a barrier between maternal and fetal blood (Lagaye et al., 2001)
and are likely to be infected if vertical transfer of the virus occurs (Douglas et al., 1991).
Our data (Boudreaux et al., 2009; Weaver et al., 2005) and the data of others (Allison and
Hoover, 2003; O'Neil et al., 1995; O'Neil et al., 1996; Rogers and Hoover, 1998, 2002)
show that like HIV, FIV is transmissible by vertical routes, despite differences in
placentation between cats and humans. Thus, the feline model is suitable for the study of
lentiviral intrauterine transmission.

5

Pregnancy Outcome in HIV and FIV infections
HIV infection of pregnant women may perturb pregnancy and negatively impact
reproductive outcome. Spontaneous fetal death was reported in a cohort of HIV-infected
American women (Langston et al., 1995). In that study, fetal loss occurred in 14 of 124
(11.3%) pregnancies evaluated during 8 to 32 weeks gestation. A 67% increase in the
risk of spontaneous abortions occurred in a study of HIV-infected Italian women
(D'Ubaldo et al., 1998). Similarly, spontaneous abortion and poor reproductive outcome
was observed in symptomatic, HIV-infected Indian women (Kumar et al., 1995).
Reproductive failure was also reported in HIV-infected, pregnant women receiving the
highly active antiretroviral therapy (HAART) in urban Nigeria (Olagbuji et al., 2009). In
that study, HIV-infected women were more likely to have intrauterine growth restriction,
preterm labor, and low birth weights when compared to HIV-negative controls.
Transmission of FIV occurs frequently in utero, often resulting in reproductive
failure (Boudreaux et al., 2009; Rogers and Hoover, 1998; Weaver et al., 2005). In
previous reports by our laboratory (Boudreaux et al., 2009; Weaver et al., 2005) and
others (O'Neil et al., 1996) FIV-B-2542-infected queens transmitted the virus to more
than 50% of their offspring. Boudreaux et al. (2009) reported that fetal non-viability
(defined as fetal resorptions or developmentally-arrested fetuses) at early gestation was
4.7% (2/43 fetuses) in control cats and 22.2% (6/27 fetuses) in FIV-infected cats. We
also reported high rates of fetal non-viability at late gestation (Weaver et al., 2005). In
that report, fetal non-viability was 3.2% (1/31 fetuses) in control cats and 60% (15/25
fetuses) in FIV-infected cats. O’Neil et al. (1995) reported higher incidences of fetal
non-viability associated with acutely-infected versus chronically-infected queens (53%
6

and 30%, respectively), and the rate of in utero FIV-infection increased with gestational
age (Rogers and Hoover, 1998). However, we detected a high rate of fetal infection by
week 3–4 gestation with 12 of 14 fetuses positive for viral RNA (Boudreaux et al., 2009).
Therefore, compromised reproductive outcome is a feature showed by FIV and HIV.
Clearly, the use of the feline model may elucidate the mechanisms of lentiviral
transplacental transfer and the impact of infection on pregnancy outcome.

The Immunology of Pregnancy
The immunology of pregnancy remains an inexplicable phenomenon and
continues to be a topic of great debate among reproductive biologists. The human
embryo and fetus are semi-allografts, and it is unclear why this allogeneic tissue is not
rejected during gestation. Immunoregulatory molecules such as cytokines and
chemokines are responsible for maternal tolerance of embryo and fetal allografts, embryo
implantation, endometrial development, the development of fetal placentation, and the
regulation of maternal cell-mediated and humoral immune responses against infection
(Bennett et al., 1998; Challis et al., 2009; Clark and Chaouat, 1989; Robertson et al.,
1994; Saito, 2001). The cytokines and chemokines that modulate pregnancy are found in
syncytio- and cytotrophoblastic cells, decidual epithelium and stroma, chorionic and
amnionic membranes, and Hofbauer cells (Wilczynski, 2005). Wegmann et al. (1993)
proposed that a Th1/Th2 cytokine paradigm exists during normal pregnancy in which
successful outcome is biased toward a Th2 (anti-inflammatory) immune response with a
suppressed Th1 (pro-inflammatory) immune response at the maternal-fetal interface.
The production of Th2 cytokines aids in the maintenance of pregnancy by
7

downregulating Th1 cytokines, thereby preventing the formation of an inflammatory
microenvironment in the placenta (Challis et al., 2009). Th1 and Th2 cytokines are
mutually antagonistic (Mosmann and Coffman, 1989; Wegmann et al., 1993). The
altered expression of the Th1 cytokine, IL-12 (a pro-inflammatory cytokine), and the Th2
cytokine, IL-10 (an anti-inflammatory cytokine), is a clear indicator of Th1:Th2 immune
shifts and cytokine dysregulation (Challis et al., 2009; Costeas et al., 2004; Romagnani,
1994; Wegmann et al., 1993). Cytokine dysregulation in the placenta may result in poor
reproductive outcome, including spontaneous abortion, preterm labor, preeclampsia, and
intrauterine growth restriction (Challis et al., 2009; Orsi and Tribe, 2008). Cytokine
dysregulation in the murine model was reported (Chaouat et al., 1995; Clark et al., 1998).
In those studies, spontaneous abortion occurred in pregnant CBA/J x DBA/2 mice when
administered exogenous Th1 cytokines (IL-2, TNF-α, and IFN-γ). However,
spontaneous abortion in pregnant CBA/J x DBA/2 mice was prevented when mice were
administered antibodies against Th1 cytokines or given the exogenous Th2 cytokines (IL10, GM-CSF, and IL-13) (Chaouat et al., 1995; Clark et al., 1998). Thus, it appears that
Th1 immunity is associated with fetal loss and that successful murine pregnancy is biased
towards a Th2 immune response. Similarly, cytokine dysregulation in human pregnancy
and subsequent spontaneous fetal loss was reported (Daher et al., 2004; Hill et al., 1995;
Lim et al., 2000; Makhseed et al., 2001; Marzi et al., 1996; Raghupathy et al., 1999;
Raghupathy et al., 2000). In those studies, women with recurrent spontaneous abortions
expressed higher levels of Th1 cytokines, IFNγ (Daher et al., 2004; Hill et al., 1995; Lim
et al., 2000; Marzi et al., 1996; Raghupathy et al., 1999; Raghupathy et al., 2000), TNF-α
(Daher et al., 2004; Raghupathy et al., 2000), and IL-2 (Hill et al., 1995; Marzi et al.,
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1996; Raghupathy et al., 2000) and decreased levels of Th2 cytokines, IL-10 (Hill et al.,
1995; Marzi et al., 1996; Raghupathy et al., 1999; Raghupathy et al., 2000) , IL-6 (Lim et
al., 2000; Raghupathy et al., 1999; Raghupathy et al., 2000), and IL-4 (Hill et al., 1995;
Marzi et al., 1996; Raghupathy et al., 2000) when compared to normal pregnant women.
Therefore it appears that, like the murine model, normal human pregnancy is biased
towards Th2 cytokine production and that Th1-type immunity is associated with
reproductive failure.
On the other hand, the Th1/Th2 paradigm of pregnancy has been challenged
(Bates et al., 2002; Chaouat, 2003; Chaouat et al., 2004a, b; Chaouat et al., 2002;
Wilczynski, 2005). Chaouat et al. (2002) suggested that this paradigm is an
‘oversimplification’ after evaluating Th1/Th2 cytokine expression at the maternal-fetal
interface of mice. For example, there was greater expression of IL-18, a Th1-type
cytokine that is responsible for the induction of IFN-γ, in the deciduas and placentas of
non-abortion-prone mice (CBA x BALB/c mating) than in abortion-prone mice (CBA x
DBA/2 mating) (Ostojic et al., 2003). Bates et al. (2002) reported increased production
of IFN-γ and decreased production of IL-10 and IL-4 in peripheral blood mononuclear
cells (PBMCs) of normal pregnant women when compared to women with recurrent
pregnancy loss (RPL). The data repudiated the hypothesis that Th1 immunity is
associated with fetal loss. Moreover, in that report, there was no significant difference in
the expression of IFN-γ, IL-10, or IL-4 in women with a history of RPL who
subsequently aborted when compared to RPL women with successful pregnancy
outcomes. Interestingly, the concentrations of TNF-α in PBMCs were similar in RPL
women with successful pregnancy outcomes and normal pregnant women. In addition,
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RPL women who subsequently aborted expressed lower concentrations of TNF-α when
compared to normal pregnant women. Other investigators have reported reduced
production of IFN-γ in uterine irrigation fluid of women with a history of recurrent
spontaneous abortions (Inagaki et al., 2003), challenging the hypothesis of cell-mediated
immunity as a detriment to pregnancy. However, the specific placental cells contributing
to immunopathology were not evaluated in those reports and it is unclear whether
infection was a contributor to reproductive failure.
The production of placental immunomodulators such as cytokines augment HIV
expression (Kedzierska and Crowe, 2001), and HIV infections can dysregulate cytokine
networks in placental tissues (Lee et al., 1997; Shearer et al., 1997). Aberrant expression
of cytokines may result in placental inflammation, and the presence of inflamed placental
membranes is likely to facilitate viral transplacental transfer (Shearer et al., 1997).
Placental trophoblastic cells can be infected with HIV (Lee et al., 2001; Lee et al., 1997;
Vidricaire et al., 2003; Zachar et al., 2002). Lee et al. (1997) evaluated the role of
placental inflammatory cytokine expression in vertical transfer of HIV. In that report, the
expression of IL-1β, IL-6, and TNF-α was evaluated in unstimulated and LPS-stimulated
trophoblast cell cultures from HIV-infected and uninfected women. Placental
trophoblasts from HIV-infected placentas expressed significantly higher amounts of IL1β, IL-6, and TNF-α than placentas from uninfected women. The data indicate that HIVinfection during pregnancy results in increased cytokine expression and that a proinflammatory microenvironment (an environment potentially conducive to vertical
transfer) exists in HIV-infected placentas. Mechanisms of maternal-fetal transcytosis of
HIV were reported (Lagaye et al., 2001; Parry et al., 2006; Vidricaire et al., 2004).
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Vidricaire et al. (2004) reported that HIV virions were internalized by polarized, human
trophoblastic JAR cells in vitro using endocytic host cell machinery. The endocytosed
virus was trafficked from the apical pole of cells, transported in a vesicular system, and
released intact at the basolateral pole. This process of membrane trafficking could allow
the virus to traverse the placenta and infect fetal trophoblastic cells. In addition,
expression of pro-inflammatory mediators such as TNF-α contributed to transcytosis of
HIV across trophoblastic cell layers (Parry et al., 2006). In that study, transcytosis of
HIV from infected peripheral blood mononuclear cells was upregulated by TNF-α.
Moreover, the presence of TNF-α did not perturb cellular viability or confluency as other
investigators reported (Garcia-Lloret et al., 1996; Yui et al., 1994). Although maternalfetal membrane trafficking clearly plays a role in HIV transplacental transfer, the affect
of aberrant placental immunomodulator expression on MTCT and reproductive outcome
remains undefined.

Placental Cytokine and Chemokine Expression in the FIV-infected Cat
Using the FIV-infected cat as a model for lentiviral transplacental transmission of
HIV, we evaluated how infection might impact the expression of placental
immunomodulators. Weaver et al. (2005) reported no significant difference in the
expression of pro-inflammatory cytokines (IFN-γ and IL-1β), or the anti-inflammatory
cytokine (IL-10) between infected and control cats. However, increased placental
expression of IFN-γ and IL-1β was associated with non-viable pregnancies. The data
suggest that, similar to HIV, FIV infections during pregnancy may result in aberrant
cytokine production and reproductive failure. Recently, we hypothesized that placental
11

expression of CD134 and CXCR4 may render the placenta vulnerable to FIV infection,
possibly facilitating efficient vertical transmission of FIV, and impact pregnancy
outcome (Scott et al., 2008). Using real-time one-step reverse transcriptase-PCR, we
quantified the relative expression of CD134 and CXCR4 mRNA from term placentas of
three groups of cats: uninfected queens producing viable offspring, experimentallyinfected queens producing only viable offspring, and experimentally-infected queens
producing viable offspring among mostly non-viable fetuses. Placentas from FIVinfected queens producing litters of only viable offspring expressed more CD134 and
CXCR4 mRNA than those from uninfected queens, suggesting that infection may cause
upregulation of the receptors. On the other hand, placentas from FIV-infected cats with
non-successful pregnancies expressed similar levels of CD134 mRNA and slightly less
CXCR4 mRNA than those from uninfected queens. Thus, it appears that cells expressing
these receptors may play a role in pregnancy maintenance.

Significance and Purpose
Although antiretroviral therapy is effective in reducing MTCT of HIV, pregnancy
remains at-risk among the population of under-developed nations where antiretroviral
therapy is not accessible. We are interested in understanding the mechanisms by which
HIV crosses the placenta to establish fetal infection and/or compromise pregnancy.
Using the FIV-infected cat model, we demonstrated frequent reproductive failure in
litters delivered at early- and late-gestation by cesarean section (Boudreaux et al., 2009;
Weaver et al., 2005). Vertical transmission of FIV occurred in nearly all pregnancies,
and FIV was detected in the tissues of both viable and non-viable kittens and fetuses.
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Litter size was larger in uninfected cats and incidences of fetal non-viability occurred at
high rates in fetuses delivered at both early- and late-gestation among FIV-infected
queens. To assess a potential role for the placental immune response in vertical
transmission and reproductive failure, we evaluated a variety of immune parameters in
placentas harvested at early- and late-gestation. We were particularly interested in
whether inflammation contributes to pregnancy outcome. We evaluated placental
expression of selected pro-inflammatory (Th1) and anti-inflammatory (Th2) cytokines,
along with FIV receptors. Th1 and Th2 cytokine expression did not differ significantly in
the placentas of infected and uninfected cats. Th1 cytokine expression was significantly
increased in placentas of FIV-infected, resorbed fetuses in comparison to placentas from
viable pregnancies (Weaver et al., 2005). These data parallel some of the immunological
abnormalities that occur in placentas of women with compromised pregnancy, including
HIV-infected pregnant women who spontaneously abort (Behbahani et al., 2000;
Courgnaud et al., 1991; D'Ubaldo et al., 1998; Kumar et al., 1995; Langston et al., 1995;
Moussa et al., 2001). We concluded that FIV infection causes abnormalities that perturb
pregnancy, probably early in gestation, leading to compromised reproduction and fetal
death. Whether this outcome is a result of virus-induced placental pathology or direct
viral attack on the developing fetus remains unknown. The specific cell populations
expressing the potentially harmful cytokines were not identified (Weaver et al., 2005). In
the present study, we hypothesized that FIV infections may cause dysregulation of
trophoblastic cytokine expression, and aberrant expression of these cytokines may
potentiate inflammation and transplacental infections. Our aim was to use the FIVinfected cat model to evaluate placental immunopathology at the cellular level, during
13

both early- and late-gestation, to begin to understand mechanistically how lentiviruses
perturb the placenta and are transmitted transplacentally, leading to fetal infection and/or
compromised pregnancy.
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CHAPTER II
EXPRESSION OF CD134 AND CXCR4 mRNA IN TERM PLACENTAS
FROM FIV-INFECTED AND CONTROL CATS

(Published in Veterinary Immunology and Immunopathology 2008; 123, 90 – 96)

Abstract
Feline immunodeficiency virus (FIV) causes a natural infection of domestic cats
that resembles HIV-1 in pathogenesis and disease progression. Feline AIDS is
characterized by depression of the CD4+ T cell population and fatal opportunistic
infections. Maternal-fetal transmission of FIV readily occurs under experimental
conditions, resulting in infected viable kittens and resorbed or arrested fetal tissues.
Although both FIV and HIV use the chemokine receptor CXCR4 as a co-receptor, FIV
does not utilize CD4 as the primary receptor. Rather, CD134 (OX40), a T cell activation
antigen and co-stimulatory molecule, is the primary receptor for FIV. We hypothesized
that placental expression of CD134 and CXCR4 may render the placenta vulnerable to
FIV infection, possibly facilitating efficient vertical transmission of FIV, and impact
pregnancy outcome. The purpose of this project was to quantify the relative expression
of CD134 and CXCR4 mRNA from the term placentas of three groups of cats:
uninfected queens producing viable offspring, experimentally-infected queens producing
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only viable offspring, and experimentally-infected queens producing viable offspring
among mostly non-viable fetuses. Total RNA was extracted from term placental tissues
from all groups of cats. Real-time one-step reverse transcriptase-PCR was used to
measure gene expression. The FIV receptors CD134 and CXCR4 were expressed in all
late term feline placental tissues. Placentas from FIV-infected queens producing litters of
only viable offspring expressed more CD134 and CXCR4 mRNA than those from
uninfected queens, suggesting that infection may cause upregulation of the receptors. On
the other hand, placentas from FIV-infected cats with non-successful pregnancies
expressed similar levels of CD134 mRNA and slightly less CXCR4 mRNA than those
from uninfected queens. Thus, it appears that cells expressing these receptors may play a
role in pregnancy maintenance.

Introduction
Globally, the estimated number of people living with HIV is 39.5 million, 2.3
million of which are children under the age of 15 years (UNAIDS/WHO, 2006). In the
United States pediatric AIDS cases (defined as AIDS occurring in children under the age
of 13 years) represent 1% of the total number of AIDS cases, with maternal-fetal
transmission of the virus accounting for more than 93% of pediatric infections (CDC,
2005). Children who are infected in utero have a more rapid progression to AIDS and
generally become symptomatic during the first year of life. In addition, HIV infection of
pregnant women often results in poor outcome, including low birth weight babies, preterm delivery, and an increased incidence of spontaneous abortions (D'Ubaldo et al.,
1998; Kumar et al., 1995; Langston et al., 1995). Specific placental cell populations are
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permissive to productive HIV infection, probably contributing to transplacental transfer
of virus or virus-infected cells across the placenta leading to fetal infection (Al-Harthi et
al., 2002; Arias et al., 2003; David et al., 1992; McGann et al., 1994). Although HIV
infection clearly has the potential to negatively impact fetal and neonatal health, the
mechanism and timing of HIV vertical transmission to the fetus is not yet clear.
FIV causes a natural infection of domestic cats that resembles HIV-1 infection in
pathogenesis and disease progression. Feline AIDS is characterized by progressive
depletion of the CD4+ T cell population and fatal opportunistic infections. Although
both viruses use the same co-receptor, the chemokine receptor CXCR4, FIV does not
utilize CD4 as the primary receptor (de Parseval et al., 2004a; Shimojima et al., 2004).
The primary FIV receptor is CD134 (OX40), a T cell activation and co-stimulatory
molecule (Shimojima et al., 2004). The virus binds these receptors via its surface
glycoprotein, gp95 (de Parseval and Elder, 2001). Previous studies demonstrated that
CXCR4 expression is essential to viral entry and that levels of CXCR4 on the host cell
were the limiting factor in productive virus infection and controlled virus spread and
cytopathogenicity (de Parseval et al., 2004b).
Vertical transmission of FIV occurs commonly in vitro (Allison and Hoover,
2003; O'Neil et al., 1996; Weaver et al., 2005). We recently reported frequent
reproductive failure in FIV-B-2542-infected cats delivered late in gestation by cesarean
section (Weaver et al., 2005). While preliminary evidence of immunopathology was
identified in the study, the interaction between the virus and its cellular receptors was not
analyzed. In the present study, we hypothesized that placental expression of CD134 and
CXCR4 may facilitate efficient vertical transmission of FIV and impact pregnancy
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outcome. Our objective was to quantify the relative expression of CD134 and CXCR4
mRNA from term placentas of experimentally-infected and control queens. We report
that the FIV receptors CD134 and CXCR4 were expressed in late term feline placental
tissues and that altered placental expression of CD134 and CXCR4 was dependent upon
FIV-status of queens and appeared to be correlated with pregnancy outcome.

Materials and Methods

Animals and virus
All procedures utilizing cats (Felis domesticus) were performed with approval of
the Mississippi State University Institutional Animal Care and Use Committee. As
previously reported (Weaver et al., 2005), cats were reproductively mature, specificpathogen-free (SPF) animals of less than 12 months old and obtained from a commercial
cattery. Ten cats were inoculated intravenously with 1 ml of a plasma pool containing
approximately 1.33 x 104 copies/ml of FIV-B-2542 originally provided by Dr. Edward
Hoover (Rogers and Hoover, 1998). Ten cats were sham inoculated with 1 ml of pooled
normal plasma. Infection was confirmed within 6 weeks p.i. by detection of FIV provirus
by PCR and for seroconversion by ELISA, and cats were allowed to naturally breed with
SPF toms. Toms used to breed uninfected females were never exposed to infected
females and vice versa. Breeding was observed, dates were recorded, and pregnancy was
confirmed by palpation and ultrasonography.
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Cesarean delivery and tissue harvest
Kittens were delivered during week 8 gestation (approximately day 56) by
cesarean section. Each kitten or fetus was removed with the associated placental
membranes. All placental tissues were snap frozen in liquid nitrogen and stored at –80°C
(Weaver et al., 2005).

Generation of study groups
The relative expression of CD134 and CXCR4 mRNA in term placental tissue
from FIV-negative (Group 1) and FIV-positive cats were evaluated. The infected cats
were subdivided into two groups, one of which consisted of cats who delivered only
viable offspring (Group 2), the other of which consisted of cats who delivered a majority
of non-viable offspring (Group 3). Due to the paucity of placental tissues associated with
fetal resorption, placentas sampled from Group 3 cats 9730 and 9813 were taken from
placentas associated with their viable fetuses. Pregnancy outcome study groups are listed
in Table 2.1.

Detection of FIV provirus in placental tissues
FIV provirus was detected in placental DNA samples using PCR targeting the
FIV gag gene, followed by Southern hybridization as described (Weaver et al., 2005).
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Table 2.1
Pregnancy Outcome of the Study Groups
Group

Queen
Number

FIV Status

Viable
kittens

Arrested
fetuses

Fetal
resorptions

1

9522
9746
9801

–
–
–

3
6
6

0
0
0

0
0
0

2

9806
9809
9810

+
+
+

3
1
1

0
0
0

0
0
0

3

9730
9813
13226

+
+
+

2
1
0

1
0
5

2
2
0

Placental tissues were taken from each associated queen according to the following
groupings—Group 1: FIV(–) queens producing viable offspring; Group 2: FIV(+)
queens producing litters of only viable offspring; Group 3: FIV(+) queens producing
viable offspring among majority non-viable litters.

Detection of antibody to FIV by ELISA
FIV was detected in feline plasma from both groups of FIV-infected queens using
the SNAP Combo FeLV Ag/FIV Antibody Test Kit (Idexx Laboratories, Westbrook,
ME) according to the manufacturer’s instructions. Positive results were scored when the
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sample produced a blue spot in the appropriate position on the membrane. A sample
from a seronegative cat was included as a negative control in a parallel reaction.

RNA extraction
RNA was isolated from 10 randomly sectioned placental tissue samples from 9
cats using TRIzol Reagent (Invitrogen, Corp. Carlsbad, CA) according to the
manufacturer’s instructions. Briefly, cells were lysed in 1 ml TRIzol Reagent.
Homogenates were allowed to sit for 5 min at ambient temperature (20–25°C) and
supplemented with 0.2 ml chloroform. Samples were covered and vigorously shaken for
15 s. The resulting mixture was allowed to sit at ambient temperature (20–25°C) for 15
min. Samples were centrifuged at 12,000 x g for 15 min at 4°C. Following
centrifugation, the colorless upper aqueous phase containing RNA was transferred to a
fresh tube. RNA was precipitated from the aqueous phase with the addition of 0.5 ml
isopropanol and incubated at ambient temperature for 10 min. The RNA precipitate was
pelleted by centrifugation at 12,000 x g for 8 min at 4°C, and the supernatant was
removed. The RNA pellet was washed by vortexing with 1 ml of 75% ethanol and
centrifuged at 12,000 x g (5 min, 4°C). The ethanol was removed, and the RNA pellet
was air-dried for 5 min. After drying, the RNA pellet was dissolved in 100 μl of RNasefree water and incubated for 15 min in a 55–60°C water bath. The resulting RNA was
stored at –80°C until use.
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Real-time reverse transcriptase-PCR
Cytokine mRNA sequences for the cat and other comparative mammals (human,
dog, cow, and pig) were obtained from the National Center for Biotechnology
Information (NCBI) and aligned using the European Molecular Biology LaboratoryEuropean Bioinformatics Institute (EMBL-EBI) ClustalW alignment tool. The human
mRNA was blast-searched against the human genome to locate the exon/intron
boundaries. These boundaries were used to find the homologous boundaries in the feline
sequence. We used Beacon Designer (PREMIER Biosoft) to design primer/probe sets
(Table 2.2) targeting the feline receptors CD134 and CXCR4, and the internal control
gene (β-actin). All PCR amplicons spanned an intron-exon junction. The target probes
were 5’ labeled with the reporter dye FAM (6-carboxyfluorescein) and 3’ labeled with
the quencher dye TAMRA (6-carboxytetramethylrhodamine). The probe for the
housekeeping gene was 5’ labeled with the reporter dye HEX (hexachloro-6carboxyfluorescein) and 3’ labeled with the quencher dye TAMRA. Primers and probes
were obtained commercially (MWG-BIOTECH, Inc., High Point, NC). Primers and
probes used to quantify FIV targeted the FIV gag gene (Weaver et al., 2005).
The real-time reverse transcriptase-PCR (rtRT-PCR) used an iCycler (BioRad
Laboratories, Valencia, CA): 50°C, 30 min; 95°C, 5 min; 45 X (95°C, 15 s, 60°C, 1
min). Each reaction contained 12.5 μl of the commercial reaction mix, 0.5 μl of
ThermoscriptTM Plus/Platinum® Taq Mix, 1 μl of forward and reverse β-actin primers
(7.5 pmol/μl), 1 μl of forward and reverse target primers (10 pmol/μl), 1 μl of the
respective probe (100 fmol/μl), ~0.06–0.27 μg RNA. For every placental RNA sample,
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Table 2.2
Sequences of PCR Primers and TaqMan Probes Specific for FIV Receptors and the
Internal Control mRNA

parallel reactions were performed in replicated triplicate reactions on separate plates for
each receptor. Real-time RT-PCR to quantify FIV gag was carried out as described
previously (Weaver et al., 2005). Serially diluted, pooled RNA from uninfected cats was
used to generate a standard curve for both duplex-partner amplicons. The standard
curves were used to normalize for differences in PCR efficiency between duplex partners
and between sample plate runs. Differences in the amount of template RNA in each
reaction were corrected by the cycle threshold (Ct) value for β-actin. Normalized
samples were divided by the calibration generating the relative expression levels.

Statistical analysis
Statistical evaluation of litter sizes and fetal viability were done using singlefactor ANOVA (Microsoft Excel-XP, Redmond, WA). To perform statistical analysis of
receptor expression, the mean normalized values for the control samples and each set of
treated samples (FIV-infected placentas) was done by using Monte Carlo resampling
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simulation with 500 iterations (Simon, 1997). Confidence intervals were calculated (α =
0.05) based on fold differences for each of the control versus treated comparisons.

Results

Pregnancy outcome
The pregnancy outcome data (Table 2.1) for FIV-infected and control queens was
previously reported (Weaver et al., 2005), and these data were used to generate three
study groups containing three randomly selected placental tissues from FIV-infected and
control queens. Control cats produced a total of 15 viable kittens, a mean litter size of 5
kittens/litter. Infected queens with litters of only viable offspring produced 5 viable
kittens, a mean litter size of 1.6 kittens/litter. Infected queens producing viable offspring
from majority non-viable litters had a total of 13 kittens, 3 of which were viable (23%)
and 10 of which were non-viable (77%). The mean litter size was 4.3 kittens/litter. Nonviable offspring were either arrested during early development (n = 6) or fetal resorptions
(n = 4). Differences in litter sizes between the three groups were significant (p = 0.05).

Detection of FIV infection
FIV provirus was detected in all but one of the placental specimens from FIVinfected cats, as reported (Weaver et al., 2005). We failed to amplify FIV provirus from
the placenta of animal 9809, although infection of the corresponding kitten was
confirmed by amplification of FIV provirus from kitten bone marrow. FIV infection of
the inoculated queens was confirmed serologically.
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Expression of CD134 and CXCR4 in placental tissues
The relative expression of CD134 and CXCR4 mRNA in near term placental
tissue was quantified, and data for the three groups of queens were compared as follows:
control queens producing viable offspring (Group 1) versus FIV positive queens
producing litters of only viable offspring (Group 2) and FIV positive queens producing
viable offspring among majority non-viable litters (Group 3) versus Group 1. Confidence
intervals were calculated (α = 0.05) for each of the control versus treated comparisons
(Fig. 2.1). If the mRNA expression between two sample sets was the same, the relative
expression was 100%.
The mRNA for FIV receptors CD134 and CXCR4 was expressed in late term
placental tissues from all groups (Fig. 2.1A and B). Group 2 queens expressed more
CD134 (mean 261%; lower and upper confidence intervals 235% and 290%,
respectively) and CXCR4 (mean 327%; lower and upper confidence intervals 287% and
371%, respectively) mRNA compared to placentas from Group 1 (Fig. 2.1A). Groups 1
and 3 queens expressed similar levels of CD134 (mean 107%; lower and upper
confidence intervals 100% and 114%, respectively) mRNA, while Group 1 expression of
CXCR4 (mean 118%; lower and upper confidence intervals 107% and 130%,
respectively) mRNA was slightly higher than that of Group 3 queens (Fig. 2.1B).

Relative expression of FIV RNA in placentas
The relative expression of FIV between the two groups of infected cats was
quantified using rtRT-PCR targeting the FIV gag gene. There were no differences in the
levels of FIV expression between the two groups (p > 0.05).
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Figure 2.1

Percentage Change in FIV Receptor mRNA Expression in Control vs.
Treated Comparisons

(A) Percentage change in CD134 and CXCR4 mRNA in placentas from infected queens
producing litters of viable offspring (Group 2) compared to control cats (Group 1). (B)
Percentage change in CD134 and CXCR4 mRNA in placentas from Group 1 cats
compared to infected queens producing viable offspring among majority non-viable
litters (Group 3). Results are shown as 95% upper (+) and lower (–) confidence intervals
around the mean (○). Relative expression was 100% if the mRNA expression between
the two sample sets was the same.
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Discussion
Transmission of FIV in utero often results in reproductive failure (Rogers and
Hoover, 1998; Weaver et al., 2005). O’Neil et al. (1996), reported no significant
difference in the litter sizes between chronically and acutely infected queens (51% and
47%, respectively), however, higher incidences of fetal non-viability were associated
with acutely infected versus chronically infected queens (53% and 30%, respectively)
(O'Neil et al., 1995). FIV-B-2542-infected queens transmitted the virus to more than
50% of their offspring (O'Neil et al., 1996; Weaver et al., 2005) and the rate of in utero
infection increased with gestational age (Rogers and Hoover, 1998). Despite the
evidence supporting efficient in utero transmission, the mechanisms by which the virus
traverses the placenta and enters the fetal circulation have not been described.
The interaction between the virus and its binding receptor(s) establishes cell
tropism and is the first event in the virus replicative cycle, yet little is known about the
expression of FIV receptors at the feline maternal-fetal interface. HIV and FIV utilize
CD4 (Dalgleish et al., 1984; Klatzmann et al., 1984) and CD134 (de Parseval et al.,
2004a; Shimojima et al., 2004), as their primary receptors, respectively. HIV-1
selectively targets CD4-bearing cells, resulting in their depletion. However, FIV has a
cell tropism that broadens with disease progression, consistent with the expression of
CD134 (Shimojima et al., 2004). HIV and FIV share usage of a common co-receptor, the
chemokine receptor CXCR4. Progression to disease in HIV-1 infections is correlated
with the ability to bind CXCR4 (Connor et al., 1997; Lu et al., 1997). Similarly,
susceptibility to infection with FIV is directly related to cellular expression of CXCR4,
levels of which have been shown to be the limiting factor in productive infection of feline
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cells (de Parseval et al., 2004b; Willett et al., 2002). Despite the use of different primary
receptors, the shared usage of CXCR4 as a cellular co-receptor by HIV and FIV
establishes similarities in cell tropism between the two lentiviruses, thus reiterating the
usefulness of the FIV-infected cat as a model for lentivirus-induced immunopathology at
the maternal-fetal interface.
The expression of CXCR4 at both the protein and mRNA levels in the human
placenta was described by Kumar et al. (2004), who reported that CXCR4 was expressed
to two-fold higher levels in early versus late human placentas. In addition, the expression
of CXCR4 was shown in all layers of the human placenta including the trophoblasts,
stroma, and endothelium (Bustamante et al., 2005). In a previous study, abundant
CXCR4 transcripts were detected in late term feline placentas, but analysis of placental
CXCR4 expression was limited to a comparison of levels in FIV-infected versus control
queens using single-factor ANOVA. The levels of CXCR4 expression between the two
groups were virtually identical (p = 0.98), indicating that FIV did not affect expression of
this chemokine receptor late in gestation (Weaver et al., 2005).
In the present study, we used real-time RT-PCR to quantify the relative
expression of CD134 and CXCR4 mRNA in placental samples from three study groups:
FIV negative (control) queens producing viable offspring (Group 1), FIV positive queens
producing litters of only viable offspring (Group 2), and FIV positive queens producing
viable offspring among majority non-viable litters (Group 3). Statistical analysis of the
mean normalized Ct values for the control versus treated comparisons was done by using
Monte Carlo resampling simulation (Simon, 1997) because the number of placental
samples obtained from queens was limited due to pregnancy failure in FIV-infected
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queens. Monte Carlo random resampling analysis results in accurate estimates with
fewer replications and is especially useful in the estimation of unpaired data sets where
sample numbers are small and parametric statistics are more prone to error. Furthermore,
confidence intervals for small sample sizes with a limited range of values can be
calculated using random sampling (Chu and Ette, 2005).
We report that CD134 and CXCR4 mRNA was expressed in all placental samples
and that CXCR4 was the more abundantly expressed receptor. To our knowledge, this is
the first report describing the expression of CD134 at the feline maternal-fetal interface.
Placentas from Group 2 cats expressed higher percentages of CD134 and CXCR4 mRNA
than those of the controls (Group 1) (Fig. 2.1A). Other investigators reported that
upregulation of CD134 and CXCR4 on CD4+ T cells occurs as a consequence of T cell
activation, enhancing the effector function of the T cells (de Parseval et al., 2004a; Joshi
et al., 2005), and that increased surface expression of CXCR4 on CD4+ T cell
populations results in increased susceptibility of these cells to FIV infection (Joshi et al.,
2005). Although we have not evaluated placental T cells directly, upregulation of CD134
and CXCR4 in the placental tissues may provide evidence of FIV-induced T cell
activation in these tissues.
Unlike the Group 2 queens, the FIV-infected queens producing non-viable fetuses
(Group 3) expressed placental CD134 mRNA at a similar level to that of Group 1
(controls), while control queens expressed slightly more CXCR4 mRNA than Group 3
queens. Collectively, these results may implicate a role for cells bearing these receptors
in feline pregnancy maintenance.
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We reported previously (Weaver et al., 2005) that FIV was detectable in 93% of
placentas examined. A comparison of relative viral RNA expression between the two
groups of infected cats evaluated in the present study revealed no significant difference in
viral expression between the two. The expression late in gestation of both the primary
receptor (CD134) and co-receptor (CXCR4) utilized by FIV may explain the frequent
placental infection. Further investigation is needed to clarify the role of cells bearing
these receptors in vertical transmission of the virus and to determine whether poor
pregnancy outcome is a direct result of viral infection of the fetus or an indirect result of
virus-induced immunopathology.
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CHAPTER III
PLACENTAL CYTOKINE DYSREGULATION IN EARLY- AND LATE-TERM
FIV-INFECTED FELINE PLACENTAS

Abstract
Typically, successful pregnancy is biased towards a Th2 immune response and a
suppressed Th1 immune response at the maternal-fetal interface early in pregnancy, while
Th1 immunity dominates late in pregnancy prior to the onset of labor. HIV infection can
alter placental cytokine patterns, but the implications for vertical transmission and
pregnancy outcome are unresolved. The FIV-infected cat is a model for HIV
transplacental transfer due to biological and clinical similarities. We found very high
rates of fetal infection and increased reproductive failure in the offspring of FIV-infected
queens delivered at early (week 3-4) and late (week 8) gestation. We hypothesized that
dysregulation of placental cytokine expression occurs in FIV-infected queens, and
aberrant expression of these cytokines may potentiate inflammation, promote vertical
transmission, and impact pregnancy outcome. The purpose of this project was to
quantify the expression of representative pro-inflammatory cytokines (IL-6, IL-12p35,
and IL-1β), the anti-inflammatory cytokine (IL-10), and the chemokine (SDF-1α) in
early- and late-term placental tissues and evaluate whether immunomodulator expression
is related to fetal FIV infection and pregnancy outcome. Total RNA was extracted from
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placental tissues, and real-time one-step reverse-transcriptase-PCR was used to measure
gene expression. Immunomodulator mRNA was expressed in all early- and late-term
placental tissues. With the exception of IL-12p35, patterns of cytokine expression in
control animals were as we predicted, Th2 cytokine mRNAs (IL-10 and IL-6) were
higher at early gestation and decreased by late gestation, while pro-inflammatory
mediator mRNAs (IL-1β and SDF-1α) were lower at early gestation and increased by late
gestation. We report that FIV-infection during early gestation was associated with
increased expression of two pro-inflammatory cytokines, IL-6 and IL-12p35, and
decreased expression of IL-10. At late gestation, IL-6 expression was significantly
increased while IL-1β and SDF-1α were decreased. Only IL-6 placental expression was
consistently affected by viral infection, increasing in FIV-infected cats at both gestational
stages. Placentas from non-viable fetuses produced decreased SDF-1α and IL-12p35.
While the impact that these immunopathological findings may have on fetal infection and
reproductive failure are not yet known, it is clear that FIV infection alters the placental
cytokine microenvironment.

Introduction
Placental cytokines and chemokines are immunoregulatory molecules that are
responsible for pregnancy maintenance. These immunomodulators are critical for
embryo implantation, endometrial development (Saito, 2001), and the development of
fetal placentation (Clark and Chaouat, 1989). Successful pregnancy is biased towards a
Th2 immune response with a suppressed Th1 response at the maternal-fetal interface
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(Challis et al., 2009; Costeas et al., 2004; Raghupathy, 1997; Wegmann et al., 1993).
Th1 and Th2 cytokines are mutually antagonistic (Mosmann and Coffman, 1989;
Wegmann et al., 1993). The production of Th2 cytokines aids in the maintenance of
pregnancy by downregulating Th1 cytokines, thereby preventing the formation of an
inflammatory microenvironment in the placenta (Challis et al., 2009). The altered
expression of the Th1 cytokine, IL-12 (a pro-inflammatory cytokine), and the Th2
cytokine, IL-10 (an anti-inflammatory cytokine), is a clear indicator of Th1:Th2 immune
shifts and cytokine dysregulation (Challis et al., 2009; Costeas et al., 2004; Romagnani,
1994; Wegmann et al., 1993). Cytokine dysregulation in the placenta may result in poor
reproductive outcome, including spontaneous abortion, preterm labor, preeclampsia, and
intrauterine growth restriction (Challis et al., 2009; Orsi and Tribe, 2008).
Perinatal transfer of HIV (defined as HIV transfer from mother-to-child during
pregnancy, labor and delivery, or breastfeeding) accounts for more than 90% of pediatric
infections worldwide (CDC, 2005). In the United States, mother-to-child transmission
(MTCT) is the most common source of all AIDS cases in children and results in 100-200
infected infants annually (CDC, 2005, 2007). The rate of disease progression in infants
is rapid and about 50% of infected newborns will succumb to the disease before 24
months of age (UNAIDS/WHO, 2009). In addition, HIV infection of pregnant women
often results in reproductive failure, including low birth weight babies, preterm delivery,
and an increased incidence of spontaneous abortions (D'Ubaldo et al., 1998; Kumar et al.,
1995; Langston et al., 1995). Although it is evident that HIV has the potential to
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negatively impact reproductive outcome, the mechanisms of viral transplacental transfer
and pregnancy perturbation associated with infection remain undefined.
HIV expression is augmented by the production of placental immunomodulators
such as cytokines (Kedzierska and Crowe, 2001), and HIV infections can dysregulate
cytokine networks in placental tissues (Lee et al., 1997; Shearer et al., 1997). Aberrant
expression of cytokines may result in placental inflammation, and the presence of
inflamed placental membranes is likely to facilitate viral transplacental transfer (Shearer
et al., 1997).
The feline immunodeficiency virus (FIV) causes a natural infection of domestic
cats that is clinically similar to HIV-1. Vertical transmission of FIV occurs in vitro,
producing infected offspring (Allison and Hoover, 2003; Boudreaux et al., 2009; O'Neil
et al., 1996; Weaver et al., 2005). Frequent reproductive failure in the FIV-infected cat
parallels the increased incidence of spontaneous abortion in HIV-infected women.
Therefore, the FIV-infected cat model is useful for the study of lentiviral transplacental
transmission.
We previously reported frequent reproductive failure in litters delivered at late
gestation by cesarean section in FIV-infected cats (Weaver et al., 2005). In that report,
vertical transmission of FIV occurred in nearly all pregnancies, and FIV was detected in
tissues of both viable and non-viable kittens and fetuses. We found that Th1 and Th2
cytokine expression did not differ significantly in the late-term placentas of infected and
uninfected cats, although the trend was toward increased expression of Th1 cytokines and
decreased expression of the Th2 cytokine (Weaver et al., 2005). However, Th1 cytokine
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expression was significantly increased in placentas of FIV-infected, resorbed fetuses in
comparison to other placentas. Although we detected preliminary evidence of
reproductive failure at late gestation, pro-inflammatory cytokine expression in early-term
placental tissue was not evaluated.
We hypothesized that dysregulation of placental cytokine expression occurs in
FIV-infected queens, and aberrant expression of these cytokines may potentiate
inflammation and impact pregnancy outcome. Our objectives were to determine the
expression of representative pro-inflammatory cytokines (IL-6, IL-12p35, and IL-1β), the
anti-inflammatory cytokine (IL-10), and the chemokine (SDF-1α) in early- and late-term
placental tissues and evaluate whether immunomodulator expression is related to FIV
infection and pregnancy outcome. We report that FIV-infection during early gestation
was associated with increased expression of two pro-inflammatory cytokines, IL-6 and
IL-12p35, and FIV-infection during late gestation was associated with increased
expression of IL-6.

Materials and Methods

Feline placental tissues
All procedures utilizing cats (Felis domesticus) were performed with approval of
the Mississippi State University Institutional Animal Care and Use Committee. As
previously reported (Boudreaux et al., 2009; Weaver et al., 2005), cats were
reproductively mature, specific-pathogen-free (SPF) animals of less than 12 months of
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age when obtained from a commercial cattery. Ten cats were inoculated intravenously
with 1 ml of a plasma pool containing approximately 1.33 x 104 copies/ml of FIV-B2542, provided by Dr. Edward A. Hoover (Rogers and Hoover, 1998). Uninfected cats
served as normal controls. Infection was confirmed by detection of FIV provirus by PCR
and for seroconversion by ELISA. All queens were allowed to naturally breed with SPF
toms. Breeding was observed and pregnancy was confirmed by ultrasonography.
Kittens were delivered by cesarean section during week 3 of gestation (earlyterm) (Boudreaux et al., 2009) and week 8 of gestation (late-term) (Weaver et al., 2005)
from FIV-B-2542-infected and uninfected queens. Placentas were collected under sterile
conditions using the following dissection procedure. The uteri were removed and
individual fetal membranes were collected. Following rinses with sterile PBS,
membranes were incised with a sterile scalpel, and fetuses and placentas were collected.
Placental tissues were snap frozen in liquid nitrogen and cryopreserved at -80°C. The
effect of FIV infection on pregnancy at early- and late-term gestation was previously
reported (Boudreaux et al., 2009; Weaver et al., 2005). For this study, we evaluated
selected placental samples from both early- and late-term pregnancy, including placentas
from both viable and non-viable pregnancies (Table 3.1).

RNA extraction
RNA was purified from frozen placental tissues of FIV-B-2542-infected and
uninfected queens at early gestation (n = 27 and n = 42, respectively) and late gestation
(n = 23 and n = 24, respectively), using TRIzol Reagent (Invitrogen, Corp. Carlsbad, CA)
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according to the manufacturer’s instructions. The RNA extraction procedure was
performed as previously reported (Scott et al., 2008).

Table 3.1
Tissues Included in the Study of Placental Immunomodulator Expression
FIV status
FIV(-)
FIV(+)
FIV status
FIV(-)
FIV(+)

Early Gestation
Viable kittens
Arrested fetuses
41
21

Fetal resorptions

0
2

Late Gestation
Viable kittens
Arrested fetuses
24
9

1
4
Fetal resorptions

0
5

0
9

Primer design of immunomodulators
Cytokine and chemokine mRNA sequences for the cat and human were obtained
from the National Center for Biotechnology Information (NCBI) and aligned using the
European Molecular Biology Laboratory-European Bioinformatics Institute (EMBL-EBI)
ClustalW alignment tool. The human mRNA was blasted against the human genome to
locate the exon/intron boundaries. These boundaries were used to find the homologous
boundaries in the feline sequence. We used Beacon Designer (PREMIER Biosoft) to
design primer/probe sets targeting the representative pro-inflammatory cytokines (IL-6,
IL-12p35, and IL-1β), an anti-inflammatory cytokine (IL-10), a chemokine (SDF-1α),
and the internal control gene (β-actin). All PCR amplicons spanned an intron-exon
junction. The target probes were 5’ labeled with the reporter dye FAM (648

carboxyfluorescein) and 3’ labeled with the quencher dye TAMRA (6carboxytetramethylrhodamine). The probe for the housekeeping gene was 5’ labeled
with the reporter dye HEX (hexachloro-6-carboxyfluorescein) and 3’ labeled with the
quencher dye TAMRA. Primers and probes were obtained commercially (MWGBIOTECH, Inc., High Point, NC). Sequences of primers and probes used in these studies
are shown in Table 3.2.

Real-time reverse transcriptase-PCR
The real-time reverse transcriptase-PCR (rtRT-PCR) used an iCycler (BioRad
Laboratories, Valencia, CA): 50°C, 30 min; 95°C, 5 min; 45 X (95°C, 15 s; 60°C, 1
min). Each reaction contained 12.5 μl of the commercial reaction mix, 0.5 μl of
Thermoscript™ Plus/Platinum® Taq Mix, 1 μl of forward and reverse β-actin primers
(7.5 pmol/μl), 1μl of forward and reverse target primers (10 pmol/μl), 1 μl of the
respective probe (100 fmol/μl), and 180–300 ng RNA. For every placental RNA sample,
parallel reactions were performed in triplicate for each gene. Standard curves were
generated from serially diluted, pooled RNA from uninfected cats and used to normalize
for differences in PCR efficiency and RNA template as previously described (Scott et al.,
2008).
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Statistical analysis
Statistical evaluation of litter sizes and fetal viability from early- and late-term
gestation were previously reported (Boudreaux et al., 2009; Weaver et al., 2005,
respectively). Statistical analysis of immunomodulator expression for early- and lateterm control and FIV-B-2542-infected placental samples were done using single-factor
ANOVA (Microsoft Excel-XP, Redmond, WA).

Results

Expression of immunomodulators in placental tissues
Immunomodulator mRNA was expressed in all early- and late-term placental
tissues. To determine normal feline placental expression of the immunomodulators
between the two stages of pregnancy, control placentas from early- and late-term
pregnancies were compared. There were significant differences in expression of all
immunomodulators in control placentas. Control placentas from early gestation
expressed more IL-10 (p = 1.57E-05) , IL-6 (p = 0.00024) and IL-12p35 (p = 1.27E-15)
mRNA than placentas from late gestation (Fig. 3.1). However, control placentas from
late gestation expressed more IL-1β (p = 7.6E-19) and SDF-1α (p = 8.68E-16) mRNA
than placentas from early gestation (Fig. 3.1).
To determine the effect of FIV infection on placental cytokine expression, FIVinfected and control placentas from both early- and late-term gestation were compared.
At early gestation, FIV-infection resulted in increased expression of the pro-
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inflammatory cytokine mRNAs, IL-6 (p = 0.001) and IL-12p35 (p = 0.0005), decreased
expression of the anti-inflammatory cytokine mRNA, IL-10 (p = 0.0007), and had no
effect on the mRNA expression of IL-1β (p = 0.57) and SDF-1α (p = 0.90) (Fig. 3.2). At
late gestation, FIV-infection resulted in increased mRNA expression of the proinflammatory cytokine IL-6 (p = 8.865E-05), decreased expression of the proinflammatory cytokines IL-1β (p = 0.0002) and SDF-1α (p = 0.004), and had no effect on
mRNA expression of IL-10 (p = 0.609) and IL-12p35 (p = 0.289) (Fig. 3.3).
To determine whether cytokine expression was related to fetal viability, placentas
from FIV-infected, viable pregnancies were compared to placentas from FIV-infected
non-viable pregnancies for both early- and late-term gestation. Of all immunomodulators
evaluated, only IL-12p35 and SDF-1α had significant differences in expression when
infected viable placentas were compared to infected non-viable placentas (Fig. 3.4 and
3.5, respectively). Differences in expression of IL-12p35 between early infected viable
placentas and non-viable placentas did not reach the level of significance (p = 0.06) (Fig.
3.4A). At late-term gestation, infected viable placentas expressed more IL-12p35 (p =
4.04E-06) mRNA than infected non-viable placentas (Fig. 3.4B). Infected viable
placentas expressed more SDF-1α mRNA than infected non-viable placentas at both
early- (p = 0.017) and late-term (p = 0.0008) gestation (Fig. 3.5A and B, respectively).
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Figure 3.1

Relative Expression of Immunomodulators in Control Cats

Real-time RT-PCR analysis of normal feline placental expression of pro-inflammatory
cytokines (IL-6, IL-12p35, and IL-1β), the anti-inflammatory cytokine (IL-10), and the
chemokine (SDF-1α) in early-term uninfected placentas (n = 42) versus late-term
uninfected placentas (n = 24). Bars represent mean Ct values substracted from a negative
endpoint (50 - mean Ct), bracketed by standard errors of the mean. P values obtained
from single factor ANOVA are noted. Alpha = 0.05.
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Figure 3.2

Relative Expression of Immunomodulators in Early-Term Feline Placentas

Real-time RT-PCR analysis of feline placental expression of pro-inflammatory cytokines
(IL-6, IL-12p35, and IL-1β), the anti-inflammatory cytokine (IL-10), and the chemokine
(SDF-1α) in early-term FIV-infected (n = 27) versus uninfected (control) (n = 42)
placentas. Bars represent mean Ct values substracted from a negative endpoint (50 mean Ct), bracketed by standard errors of the mean. P values obtained from single factor
ANOVA are noted. Alpha = 0.05.

54

Figure 3.3

Relative Expression of Immunomodulators in Late-Term Feline Placentas

Real-time RT-PCR analysis of feline placental expression of pro-inflammatory cytokines
(IL-6, IL-12p35, and IL-1β), the anti-inflammatory cytokine (IL-10), and the chemokine
(SDF-1α) in late-term FIV-infected (n = 23) versus uninfected (control) (n = 24)
placentas. Bars represent mean Ct values substracted from a negative endpoint (50 mean Ct), bracketed by standard errors of the mean. P values obtained from single factor
ANOVA are noted. Alpha = 0.05.
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Figure 3.4

Relative Expression of IL-12p35 in Placentas from FIV-infected Cats

Comparison of IL-12p35 expression in placentas from viable and non-viable pregnancies
in FIV-infected cats. (A) early placentas from viable pregnancies (n = 21) versus nonviable pregnancies (n = 6); (B) late-term placentas from viable pregnancies (n = 9) versus
non-viable pregnancies (n = 14). Bars represent mean Ct values substracted from a
negative endpoint (50 - mean Ct), bracketed by standard errors of the mean. P values
obtained from single factor ANOVA are noted. Alpha = 0.05.
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Figure 3.5

Relative Expression of SDF-1α in Placentas from FIV-infected Cats

Analysis of fetal viability and expression of the chemokine (SDF-1α) in placentas
obtained from (A) early-term FIV-infected viable (n = 21) versus infected non-viable (n =
6) pregnancies and (B) late-term FIV-infected viable (n = 9) versus infected non-viable
(n = 14) pregnancies. Bars represent adjusted mean Ct values and error bars represent
standard errors of the mean. P values obtained from single factor ANOVA are noted.
Alpha = 0.05.
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Discussion
HIV infection of pregnant women may perturb pregnancy and negatively impact
reproductive outcome. Langston et al. (1995) reported spontaneous abortions in HIVinfected women with fetal loss occurring in 11.3% (14/124) of pregnancies evaluated. A
67% increase in the risk of spontaneous abortions occurred in a study of HIV-infected
Italian women (D'Ubaldo et al., 1998). Similarly, spontaneous abortion and poor
reproductive outcome was observed in symptomatic, HIV-infected Indian women
(Kumar et al., 1995). Reproductive failure was also reported in HIV-infected, pregnant
women receiving the highly active antiretroviral therapy (HAART) in urban Nigeria
(Olagbuji et al., 2009). In that study, HIV-infected women were more likely to have
intrauterine growth restriction, preterm labor, and low birth weights when compared to
HIV-negative controls.
Similar to HIV, transmission of FIV occurs frequently in utero under
experimental conditions, resulting in reproductive failure (Boudreaux et al., 2009; Rogers
and Hoover, 1998; Weaver et al., 2005). Therefore, the FIV-infected, pregnant queen is a
useful model to study lentiviral transplacental transfer and the impact of infection on
pregnancy outcome. In a previous study by our laboratory (Boudreaux et al., 2009), fetal
non-viability at early gestation was 4.7% in control cats and 22.2% in FIV-infected cats.
We also reported high rates of fetal non-viability at late gestation (Weaver et al., 2005).
O’Neil et al. (1995) reported higher incidences of fetal non-viability associated with
acutely-infected versus chronically-infected queens (53% and 30%, respectively), and the
rate of in utero FIV-infection increased with gestational age (Rogers and Hoover, 1998).
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Despite the evidence supporting efficient in utero transmission of FIV, the mechanisms
by which the virus traverses the placenta and affects fetal viability have not been
elucidated.
In typical, normal pregnancy, Th2 (anti-inflammatory) cytokines are favored at
the maternal-fetal interface at early pregnancy, then a shift toward Th1 (proinflammatory) cytokine dominance occurs during late pregnancy in preparation for the
onset of labor (Challis et al., 2009). The anti-inflammatory environment suppresses the
maternal cell-mediated immune response in the placenta, allowing maternal tolerance of
the semi-allogeneic fetus (Lim et al., 1998, 2000; Raghupathy, 1997; Raghupathy et al.,
1999; Raghupathy et al., 2000). No such information has been published for the cat. In
the present study, we used real-time RT-PCR to quantify the expression of representative
pro-inflammatory cytokines IL-6 (which is also a Th2 cytokine), IL-12p35, and IL-1β,
the Th2 cytokine IL-10, and the chemokine SDF-1α in early- and late-term feline
placental tissues. To determine the normal pattern of expression, we first compared data
obtained from early and late placentas from normal cats only. We detected
immunomodulator mRNA in all placental tissues from both early- and late-term
gestation. The two Th2 cytokines were expressed to higher levels at early pregnancy and
two pro-inflammatory mediators (IL-1β and SDF-1α) were expressed to higher levels at
late gestation. The expression of only IL-12p35 failed to match the predicted pattern.
The pattern of expression of IL-6 was similar to that reported by Moussa et al. (2001)
who also found that IL-6 was expressed to higher levels in first trimester human
chorionic villi than later in pregnancy. IL-6 is a pleiotropic cytokine produced by
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trophoblasts, macrophages, and Th2 cells. IL-6 regulates expression of human chorionic
gonadotropin (HCG) from trophoblasts by activating IL-6 receptor-mediated signal
transduction (Masuhiro et al., 1991). Therefore, its expression during early pregnancy is
essential. Whether this cytokine plays a role in feline reproductive hormone expression is
unknown.
HIV infection alters cytokine expression in placental tissue. Lee et al. (1997)
reported increased levels of IL-1β, IL-6, and TNF-α in trophoblasts isolated from HIVinfected human term placentas collected immediately after delivery. On the other hand,
other investigators have reported decreased espression of IL-6 and other inflammatory
cytokines and β-chemokines in HIV-infected term placentas (Moussa et al., 2001). The
dysregulation of placental cytokines in both HIV (Shearer et al., 1997; Weetman, 1999)
and FIV (Weaver et al., 2005) infections was associated with increased incidence of
reproductive failure. Shearer et al. (1997) suggested that HIV infection causes altered
expression of maternal and fetal Th1 and Th2 cytokines, leading to fetal rejection and
spontaneous abortion. Moreover, increased expression of Th1 cytokines and decreased
expression of a Th2 cytokine (IL-10) was associated with spontaneous abortion and lowbirth weight infants born to HIV-infected women (Weetman, 1999). In a comparison of
cytokine expression in placentas collected from viable versus non-viable pregnancies, we
found elevated expression of inflammatory cytokines interferon (IFN)-γ and IL-1β and
increased Th1/Th2 ratios (IL-1β/IL-10) in placentas from resorptions, indicating
increased placental pro-inflammatory cytokine expression was associated with failed
pregnancy (Weaver et al., 2005). Reports on the effect of HIV-1 on reproductive
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hormone expression is limited, but maternal serum human chorionic gonadotropin (HCG)
and α-fetoprotein levels were increased in HIV-infected women at delivery, correlative
with increased viral load and decreased CD4+ T cell counts (Gross et al., 2003).
To determine how FIV infection might impact expression of these cytokines, we
compared their expression in placentas obtained from both control and infected animals
at early and late pregnancy. At early gestation, FIV infection increased the expression of
the pro-inflammatory cytokines IL-6 and IL-12p35, decreased the expression of the antiinflammatory cytokine IL-10, and had no effect on IL-1β and SDF-1α. While the source
of IL-12 in the placenta was not defined, it is known to be a product of activated
macrophages and a potent inducer of the Th1 response and NK cell activation (Sutterwala
and Mosser, 1999). Collectively, the data point toward a virus-induced pro-inflammatory
microenvironment at early gestation, which is generally not supportive of fetal survival.
Given the increased rate of reproductive failure that we found at early and late gestation,
it appears that early placental immunopathology may have been a contributor. At late
gestation, FIV infection increased the expression of the pro-inflammatory cytokine IL-6,
decreased the expression of the pro-inflammatory cytokines IL-1β and SDF-1α, and had
no effect on the expression of IL-10 and IL-12p35. While we do not know the function
that IL-6 plays in the feline placenta, its consistently-increased expression in infected
placentas at early and late term suggests it may be a key cytokine in virus-induced
placental immunopathology. Other investigators reported increased levels of IL-6
(Lawrence et al., 1995; Ohashi et al., 1992) and IL-12 (Dean and Pedersen, 1998) in
FIV-infected, symptomatic cats. In addition, Lawrence et al. (1995) reported that
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increased production of IL-6, IL-1, and tumor necrosis factor (TNF) was associated with
impaired immune responses and clinical symptoms of feline AIDS.
We predicted that we would detect evidence of a pro-inflammatory
microenvironment in placentas from infected, non-viable pregnancies versus those of
infected, viable pregnancies. We did not see this pattern. Only IL-12p35 and SDF-1α
expression differed between viable and non-viable placentas. IL-12p35 was expressed to
lower levels in late, non-viable placentas than viable ones, and SDF-1α was expressed to
lower levels in both early and late non-viable placentas, and the data were highly
significant. This pattern is opposite our prediction, and we do not yet have an
explanation for this finding.
The key to understanding the relevance of these data is to identify the placental or
decidual cells that are a source of these cytokines. Trophoblasts are fetal-derived cells
that produce numerous cytokines that regulate placental function (Bennett et al., 1996;
Bennett et al., 1998; Guilbert et al., 1993; Roth et al., 1996; Wilczynski, 2005). Maternal
regulatory T cells (Tregs), located in the deciduum, produce cytokines that suppress
inflammation (Maloy et al., 2003). Both of these cell populations can be infected by
HIV, and feline Tregs were shown to support the replication of FIV (Joshi et al., 2005;
Joshi et al., 2004). In the event that these cell populations were infected with FIV in our
study, then viral infection leading to depletion or altered function of these cells may
explain abnormal cytokine patterns. Our laboratory is currently exploring the role of
trophoblasts and placental Tregs in lentivirus-induced immunopathology and pregnancy
failure.
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CHAPTER IV
A NOVEL IMMUNOHISTOCHEMICAL ASSAY TO DETECT TROPHOBLASTS
IN FELINE PLACENTA

Abstract
The placenta, a fetal endocrine organ, is composed of a subpopulation of
trophoblasts, cytotrophoblasts and syncytiotrophoblasts. Trophoblastic populations can
be distinguished based upon their expression of cytokeratin. The purpose of this project
was to develop an immunohistochemistry (IHC) method to identify trophoblasts
selectively in frozen feline placental tissue using antibodies specific for cytokeratin. We
used the mouse monoclonal antibody anti-human pan-cytokeratin AE1/AE3 and the
detection system DAKO EnVision System, HRP. We encountered non-specific
immunoreactivity that could not be eliminated with altered blocking methods. The nonspecific reactivity was attributed to the goat anti-mouse/rabbit IgG peroxidase polymer
included in the kit. Alternatively, we used a polyclonal rabbit anti-cow cytokeratin wide
spectrum screening (WSS) antibody with goat anti-rabbit IgG polyclonal secondary
antibody to detect cytokeratin in feline placental tissue. This IHC procedure eliminated
non-specific immunoreactivity while specifically labeling cytokeratin. This new
approach provides an innovative IHC method to identify trophoblasts in feline placenta.
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Introduction
The placenta, an endocrine organ of fetal origin, is responsible for metabolic
exchange between the mother and the developing fetus (Senger, 2003). This organ
produces hormones that are responsible for pregnancy maintenance and fetal growth
(Senger, 2003). Trophoblastic cells (cytotrophoblasts and syncytiotrophoblasts) are a
population of cells that comprise the placental chorionic villi. These trophoblasts are
fetal-derived cells of epithelial origin that cover the blastocyst and form the chorion, the
fetal portion of the placenta (Senger, 2003). Syncytiotrophoblasts comprise the outer
trophoblast layer, contacting and forming attachment with the maternal endometrium
(Senger, 2003). The cytotrophoblasts form the inner layer of the trophoblast between the
syncytiotrophoblasts and the chorionic villous capillaries. Placental trophoblasts express
unusual immunological markers, including HLA-G and other Class I molecules that
regulate immune suppression (Kovats et al., 1990; Szekeres-Bartho, 2002) and cytokines
that regulate immune function (Baergen et al., 1994; Moussa et al., 2001). The
immunological characteristics of trophoblastic cells contribute to the immunological
privilege of the placenta, promoting fetal tolerance and successful pregnancy.
As a part of an ongoing study of feline immunodeficiency virus (FIV) vertical
transmission and virus-induced placental immunopathology, we were interested in the
impact of viral infection on gene expression by trophoblasts. Our initial goal was to
develop an immunohistochemistry method to identify trophoblasts in feline placental
tissue based on their expression of cytokeratin intermediate filaments. We attempted to
detect cytokeratin antigens using the mouse anti-human pan-cytokeratin monoclonal
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antibody AE1/AE3 and DAKO EnVision System, HRP kit, which utilizes a goat antimouse/rabbit IgG peroxidase-labeled polymer as a secondary antibody. However, in
feline placentas this system produced non-specific reactivity which could not be
eliminated with modification of protocol. Thus, we developed an innovative IHC
procedure utilizing a polyclonal rabbit anti-cow cytokeratin wide spectrum screening
(WSS) antibody paired with goat anti-rabbit Poly-HRP secondary antibody to detect
cytokeratin in feline placental tissue. This procedure resulted in specific staining of
cytokeratin in feline trophoblasts, eliminating non-specific antibody binding.

Materials and Methods

Feline placental tissues
All procedures utilizing cats (Felis domesticus) were performed with approval of
the Mississippi State University Institutional Animal Care and Use Committee. Cats
used in this investigation were part of an ongoing study of FIV-B-2542 (Rogers and
Hoover, 1998) transplacental transmission. Cats were reproductively mature, specificpathogen-free (SPF) animals of less than 12 months of age when obtained from a
commercial cattery. Uninfected cats served as normal controls. All queens were allowed
to breed naturally with SPF toms. Breeding was observed and pregnancy was confirmed
by palpation and ultrasonography.
Kittens were delivered by cesarean section during week 8 of gestation (late-term)
(Weaver et al., 2005). Placentas were collected under sterile conditions using the
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following dissection procedure. The uteri were removed and individual fetal membranes
were collected. Following rinses with sterile PBS, membranes were incised with a sterile
scalpel, and fetuses and placentas were collected. Placental tissues were snap frozen in
liquid nitrogen and cryopreserved at -80°C. Tissues from control cats only were used in
the following procedures.

Histological evaluation of placental tissues
OCT-embedded placental sections from a late-term control queen were fixed in
acetone for 10 min and allowed to dehydrate for 1 min. Following dehydration, routine
hematoxylin and eosin (H&E) staining was performed to observe histology as follows.
Placental tissues were stained with Mayer’s hematoxylin (Sigma, St. Louis, MO) for 15
min and washed under tap water for 20 min. Sections were counterstained with eosin for
2 min and dehydrated sequentially in two changes of 95% and 100% EtOH, 2 min each.
After a 1 min dehydration at room temp, sections were cleared twice with 2 min xylene
rinses, and mounted with Permount (Fisher Scientific, Waltham, MA).

Basic immunohistochemistry procedure
All IHC procedures were performed using the following basic staining protocol
with modifications only to endogenous peroxidase quenching, serum pretreatments, and
antibody incubations. Frozen placental tissues were cryosectioned to 4 μm and placed
onto poly-L-lysine coated slides (Lab Scientific, Inc., Livingston, NJ). Sections were
allowed to air dry at room temp overnight. Dried sections were fixed in acetone for 10
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min at room temp and allowed to air dry completely. To quench endogenous peroxidase
activity, sections were blocked with the commercial peroxidase blocking reagent (DAKO
EnVision; Dako Corp., Carpinteria, CA) for 10 min and washed in a bath of Tris-buffer
(TB; 0.05 M Tris-HCl, pH 7.0-7.6). The primary antibody or negative control reagent
was diluted 1:50 in TB containing 1% bovine serum albumin (BSA). Sections were
incubated with either the mouse anti-human pan-cytokeratin monoclonal antibody
AE1/AE3 (Dako Corp.) or the mouse universal negative control reagent (Dako Corp.) for
10 min. Following the incubation of the primary antibody or the negative control
reagent, sections were washed in separate baths of TB. Sections were then incubated
with the goat anti-mouse/rabbit IgG peroxidase-labeled polymer (DAKO EnVision, HRP)
for 10 min and washed in a fresh bath of TB. Sections were incubated with the buffered
substrate solution containing 3,3'-diaminobenzidine (DAB) chromogen (Dako Corp. or
Invitrogen, Carlsbad, CA) for 10 min and washed in a bath of distilled water for 1 min.
Sections were then counterstained with Mayer’s hematoxylin (Sigma) for 5 min and
rinsed in fresh, distilled water for 1 min. The counterstain was blued by dipping sections
10 times in a bath of 37 mM ammonia and rinsing sections in a fresh bath of distilled
water. Sections were dehydrated in 75%, 95%, and 100% EtOH for 30 sec and xylene
for 5 min. Immunoreactivity was detected microscopically.

Endogenous peroxidase quenching and tissue blocking
Dehydrated sections were blocked by sequential pretreatment with both mouse
and goat serum (1:100) for 10 min each. Blocking serum was removed from the slides,
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and unrinsed sections were quenched with peroxidase blocking reagent (DAKO
EnVision, HRP). Alternatively, dehydrated sections untreated with sera were quenched
for 30 min with a solution of 2 ml 30% H2O2 (Sigma) and 400 ml methanol (Champion et
al., 2003). Quenched sections were blocked with 5% (w/v) non-fat dry milk in TB
(Blotto) for 1 hr 15 min.

Modified IHC Procedure
Sections quenched with peroxidase blocking reagent were incubated with mouse
antibodies (as previously described) using the following conditions: no antibody,
primary antibody only, and secondary antibody only. Sections quenched with H2O2 in
methanol and blocked with Blotto were incubated with the polyclonal rabbit anti-cow
cytokeratin wide spectrum screening (WSS) antibody (Dako Corp.) or rabbit universal
negative control reagent (Dako Corp.) and secondary goat anti-rabbit, Poly-HRP
(Chemicon International, Inc., Temecula, CA).

Antibodies
All antibodies used in these assays are shown in Table 4.1.
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Table 4.1
Antibodies Used in Immunohistochemistry

Results

Histological evaluation of placental tissues
Hematoxylin and eosin staining of the placental tissue revealed the location of
trophoblasts and provided confirmation that tissue integrity was not compromised during
cryopreservation and frozen storage (Fig. 4.1).
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Immunohistochemistry
The results of all IHC methods are listed in Table 4.2.

TC

Figure 4.1

Histological Evaluation of Late-Term Feline Placenta

Placental tissues were cryosectioned to a thickness of 4 μm, fixed in acetone, and
dehydrated. Sections were stained with hematoxylin and eosin. The location of
trophoblastic cells (TC) (arrows) is shown. Magnification: 100X.

IHC using AE1/AE3 mouse monoclonal antibodies and the DAKO EnVision, HRP kit
We used the mouse anti-human pan-cytokeratin monoclonal antibody AE1/AE3
and a negative control reagent with the DAKO EnVision System, HRP kit to detect
cytokeratin in acetone-fixed, frozen placental tissues. Immunolabeling revealed similar
immunoreactivity in tissues treated with the mouse monoclonal antibody AE1/AE3 and
the negative control reagent (Fig. 4.2), indicating non-specific labeling in our IHC
procedure.
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Parallel placental sections were stained for cytokeratin using serum pretreatments
and modified antibody conditions. Cytokeratin labeling did not occur in sections
subjected to the protocol in the absence of both primary and secondary antibody or
sections that were treated with only the primary mouse monoclonal (Fig. 4.2C and 4.2D,
respectively), suggesting that endogenous peroxidase activity was not the cause of nonspecific labeling. Sections that were treated with the goat anti-mouse/rabbit IgG
peroxidase polymer alone had concentrated areas of non-specific labeling (Fig. 4.2E),
indicating that this secondary antibody was non-specifically reactive.

Novel immunohistochemistry technique using alternative antibodies
To overcome problems with non-specific immunoreactivity, alternative antibody
pairs were used to target placental tissue sections. Sections treated with the polyclonal
rabbit anti-cow cytokeratin primary antibody (1:50 or 1:100) followed by secondary
antibody developed strong, specific binding to cytokeratin (Fig. 4.3A). Sections treated
with either secondary antibody alone (Fig. 4.3B) or with rabbit universal negative control
antibody followed by secondary antibody (Fig. 4.3C) did not stain with chromogen.
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Table 4.2
Summary of Methods Used to Detect Cytokeratin Antigens in Feline Placental Tissues
Quenching/
Blocking Agent

Primary (1°)
Antibody

Secondary (2°)
Antibody

Result

Peroxidase blocking
reagent (DAKO EnVision)

Mouse universal
negative control
(1:50) (Dako)

Goat antimouse/rabbit IgG
peroxidase polymer
(DAKO EnVision)

Non-specific
binding

Peroxidase blocking
reagent (DAKO EnVision)

Mouse monoclonal
AE1/AE3 (1:50)
(Dako)

Goat antimouse/rabbit IgG
peroxidase polymer
(DAKO EnVision)

Non-specific
binding

Mouse and goat sera;
peroxidase blocking reagent
(DAKO EnVision)

NONE

NONE

No staining

Mouse and goat sera;
peroxidase blocking reagent
(DAKO EnVision)

Mouse monoclonal
AE1/AE3 (1:50)
(Dako)

NONE

No staining

Mouse and goat sera;
peroxidase blocking reagent
(DAKO EnVision)

NONE

Goat antimouse/rabbit IgG
peroxidase polymer
(DAKO EnVision)

Non-specific
binding

H2O2 in methanol; Blotto

NONE

Goat anti-rabbit IgG,
Poly-HRP
(Chemicon)

No staining

H2O2 in methanol; Blotto

Polyclonal rabbit
anti-cow
cytokeratin (1:50)
(Dako)

Goat anti-rabbit IgG,
Poly-HRP
(Chemicon)

Strong, specific
antigen binding

H2O2 in methanol; Blotto

Rabbit universal
negative control
(1:100) (Dako)

Goat anti-rabbit IgG,
Poly-HRP
(Chemicon)

No staining

H2O2 in methanol; Blotto

Polyclonal rabbit
anti-cow
cytokeratin (1:100)
(Dako)

Goat anti-rabbit IgG,
Poly-HRP
(Chemicon)

Strong, specific
antigen binding
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Figure 4.2

Immunohistochemistry using AE1/AE3 Mouse Monoclonal Antibodies
and the DAKO EnVision, HRP kit

Placental tissues were cryosectioned to a thickness of 4 μm, fixed in acetone, and
dehydrated. Immunostaining of late-term feline placental tissue sections using mouse
monoclonal antibodies and the EnVision kit resulted in non-specific immunoreactivity.
Arrows show chromogen staining. Magnification: 100X. (A) Sections labeled with the
mouse universal negative control reagent and (B) sections labeled with the mouse
monoclonal antibody AE1/AE3 followed by the secondary antibody goat antimouse/rabbit IgG peroxidase polymer stained with the chromogen. (C) Unlabeled
sections and (D) sections treated only with mouse monoclonal AE1/AE3 did not stain.
(E) Sections labeled only with secondary antibody goat anti-mouse/rabbit IgG peroxidase
polymer produced strong, non-specific staining.
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Figure 4.3

Immunohistochemistry using Alternative Antibodies

Placental tissues were cryosectioned to a thickness of 4 μm, fixed in acetone, and
dehydrated. Immunohistochemical staining of late-term feline placental tissue using
polyclonal antibodies produced specific immunoreactivity to cytokeratin. Magnification:
100X. (A) Sections stained with the polyclonal antibody rabbit anti-cow cytokeratin
followed by secondary antibody goat anti-rabbit, Poly-HRP resulted in strong
immunoreactivity to cytokeratin (brown stain). (B) Sections stained with only secondary
antibody goat anti-rabbit, Poly-HRP did not stain with chromogen. (C) Sections stained
with the rabbit universal negative control antibody and secondary goat anti-rabbit, PolyHRP did not stain with chromogen.
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Discussion
To determine the role of trophoblasts in FIV-induced placental immunopathology,
it was important for us to identify trophoblasts in feline placental tissue by IHC. To
identify these cells we targeted cytokeratin, a marker for trophoblasts. We began our
investigation by using the mouse anti-human pan-cytokeratin monoclonal antibody
AE1/AE3 with a traditional IHC kit (DAKO EnVision, HRP). The use of anticytokeratin monoclonal antibodies to identify trophoblastic cellular populations with
immunohistochemistry has been described in detail in both the human and feline placenta
(Joling et al., 1996; Kadyrov et al., 2007; Muhlhauser et al., 1995; Walter and Schonkypl,
2006). Mulhauser et al. (1995) identified villous and extravillous human trophoblast
populations throughout pregnancy in frozen sections using monoclonal antibodies
directed against cytokeratin. Recently, anti-cytokeratin monoclonal antibodies were used
to evaluate the distribution of cytokeratin intermediate filaments in feline fetal chorionic
lamellae (Walter and Schonkypl, 2006). However, our immunostaining revealed nonspecific immunoreactivity in feline placental tissues labeled with the mouse monoclonal
AE1/AE3 and goat anti-mouse/rabbit IgG peroxidase polymer which we were unable to
resolve with altered blocking techniques.
Non-specific reactivity of the goat anti-mouse/rabbit IgG peroxidase polymer was
demonstrated by reactivity to placental protein in a western blot assay (data not shown).
Likewise, we attributed non-specific immunoreactivity in our IHC procedure to this
secondary antibody. This DAKO EnVision, HRP kit component appears to be an
unreliable IHC reagent for labeling feline placental tissue. Although we did not
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specifically pinpoint the reliability of the monoclonal antibody AE1/AE3 in our tissues,
this antibody failed to bind cytokeratin reliably in a majority of normal feline epithelial
tissues in a previous report (Peaston et al., 1992).
Honig et al. (2005) reported non-specific immunoreactivity in IHC of human
placental tissues when attempting to identify dendritic cells by immunolabeling with
mouse anti-CD83 monoclonal antibodies and HLA-G by immunolabeling with specific
mouse monoclonal antibody. In that study, non-specific immunoreactivity occurred
when mouse isotype IgG2b was used. Non-specific binding of mouse antibody IgG2b
isotype to endothelial cells in human chorionic villi was prevented by blocking tissues
with purified human IgG, which contained a mixture of antibody isotypes. Although the
reason for non-specific immunoreactivity was unproven, it was attributed to inappropriate
antibody binding to placental Fc receptors with an affinity for the mouse immunoglobulin
Fc domain. Interestingly, the placentas of both humans and mice possess hemochorial
placentation, similar mechanisms of IgG transport from mother to fetus, and an “antigenindependent” affinity for antibody (Honig et al., 2005; Lyden et al., 2001; Simister,
2003).
Likewise, we have encountered non-specific immunoreactivity of a panel of
mouse monoclonal and some polyclonal antibodies to feline placenta in IHC and
immunofluorescence procedures (data not shown). Here, our approach to eliminate this
problem was to use a rabbit polyclonal antibody to bovine cytokeratin and secondary goat
anti-rabbit, Poly-HRP, along with adjusted quenching and blocking procedures. These
modifications resulted in specific cytokeratin labeling. An alternative approach that has
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been shown effective in avoiding Fc receptor non-immune adherence is the use of Fab or
F(ab’)2 portions of the IgG molecule rather than the whole IgG molecule in
immunoassays (Ramos-Vara, 2005). We have not attempted IHC in feline tissues with
these fragmented antibodies.
Our data confirm that like human placental tissue, the feline placenta presents a
unique challenge to the use of immunolabeling for detection of placental antigens. Our
innovative approach to feline placental immunohistochemistry provides a useful
alternative method for specifically targeting feline cytokeratin antigen and may provide a
basis for targeting other placental antigens with appropriate immunoreactivity.

Conclusions
Non-specific immunoreactivity of feline placental tissues presents a challenge
when attempting immunoassays to identify specific antigen in these tissues. We
developed an innovative immunohistochemistry procedure utilizing a wide spectrum
rabbit polyclonal antibody and goat anti-rabbit secondary polyclonal antibody to label
cytokeratin specifically in feline trophoblasts and eliminate non-specific
immunoreactivity. Our novel IHC protocol is detailed in Table 4.3.
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Table 4.3
Immunohistochemistry Protocol for Trophoblast Staining in Frozen Feline
Placental Tissues
Step

Procedure

1
2
3
4
5
6
7

Fix with room temperature acetone
Air dry
Quench with H2O2 in methanol
Wash in 0.05 M Tris-HCl
Block with 5% Blotto
Wash in 0.05 M Tris-HCl
Incubate with rabbit anti-cow 1° Ab in 0.05 M Tris-HCl + 1% BSA

8
9
10
11
12
13
14
15
16

Wash in 0.05 M Tris-HCl
Incubate with goat anti-rabbit 2° Ab at room temperature
Wash in 0.05 M Tris-HCl
Incubate with DAB
Wash by dipping in dH2O
Counterstain with Mayer’s Hematoxylin
Wash by dipping in dH2O
Blue hematoxylin by dipping in 37 mM ammonia
Dehydrate:
- 75% EtOH
- 95% EtOH
- 100% EtOH
- Xylene
- Dry in fume hood

17

Mount in Permount
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Duration

10 min
5 min
30 min
2 x 5 min
1 hr 15 min
2 x 5 min
Overnight
at 4°C
2 x 5 min
1 hr
2 x 5 min
15 min
3 x 3 sec
5 min
3 x 3 sec
10 x 2 sec
30 sec
30 sec
30 sec
5 min
5 min
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CHAPTER V
HISTOLOGICAL EVALUATION OF FROZEN FELINE PLACENTAL TISSUES
AND IMMUNOHISTOCHEMICAL LOCALIZATION AND COLLECTION
OF PLACENTAL TROPHOBLASTS

Introduction
Maternal-fetal transmission of the human immunodeficiency virus (HIV)
frequently results in infected babies or miscarriage (D'Ubaldo et al., 1998; Kumar et al.,
1995; Langston et al., 1995). HIV-infections may dysregulate placental cytokines and
induce inflammation and transplacental infections (Salazar-Gonzalez, 1997; Sinicco,
1993). The feline immunodeficiency virus (FIV) is a lentivirus in cats that resembles
HIV in biology and clinical disease. FIV infection of queens results in frequent
reproductive failure (Allison and Hoover, 2003; Boudreaux et al., 2009; Weaver et al.,
2005). Th1 cytokine expression is increased in placental tissues from resorbed
pregnancies (Weaver et al., 2005), yet the specific placental cells contributing to
immunopathology have not been identified. We are interested in evaluating the
expression of representative placental cytokines in cells known to produce numerous
immunomodulators during gestation, the trophoblasts. We hypothesized that aberrant
immunomodulator expression in trophoblasts contributes to placental immunopathology,
possibly facilitating vertical transfer of FIV and/or reproductive failure. The purpose of
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this project was to histologically evaluate the integrity of frozen feline placental tissues
and selectively identify and collect placental trophoblasts from early- and late-term FIVinfected and non-infected queens.

Materials and Methods

Animals and virus
Cats were reproductively mature, specific-pathogen-free (SPF) animals (Felis
domesticus) obtained from a commercial cattery. Experimental cats were inoculated
intravenously with a feline plasma pool containing FIV-B-2542. Infection was confirmed
within 6 weeks by detection of FIV provirus by PCR and for seroconversion using the
PetChek® FIV Antibody Test Kit (IDEXX Laboratories, Inc., Westbrook, ME). The cats
were allowed to naturally breed with SPF toms. Breeding was observed and pregnancy
was confirmed by palpation and ultrasonography.

Placental tissue harvest
Kittens were delivered by cesarean section during week 3-4 of gestation (earlyterm) and week 8 gestation (late-term) from FIV-infected and control queens. Placentas
were collected under sterile conditions using the following dissection procedure. The
uteri were removed and individual fetal membranes were collected. Following rinses
with sterile PBS, membranes were incised with a sterile scalpel, and placentas were
collected. Placental tissues were snap frozen in liquid nitrogen and cryopreserved at
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-80°C. Eight placental tissues each from both early- and late-term queens were used in
this study.

Histological evaluation of placental tissues
OCT-embedded placental sections from all tissues were fixed in acetone for 10
min and allowed to dehydrate for 1 min. Following dehydration, routine hematoxylin
and eosin (H&E) staining was performed to observe histology. Sections were mounted
with Permount (Fisher Scientific, Waltham, ME) and viewed microscopically using the
Veritas™ Microdissection Instrument (Arcturus Bioscience, Inc., MountainView, CA).

Immunohistochemistry (IHC) to detect trophoblasts
Snap frozen placental tissues were embedded in OCT, sectioned to a thickness of
10 μm using a cryostat, and placed on RNase-free glass membrane slides (Molecular
Devices, Sunnyvale, CA). Sections were fixed with acetone at room temperature (20–
25ºC). Endogenous peroxidase activity in dehydrated sections was quenched with 400
ml methanol / 2 ml 30% H2O2 solution. Quenched sections were washed in 0.05 M TrisHCl buffer (TB) (pH 7.0–7.6). To prevent non-specific immunological binding, sections
were blocked with 5% (w/v) non-fat dry milk in TB (Blotto) and washed in 0.05 M TrisHCl buffer (pH 7.0–7.6). Trophoblasts were stained with a polyclonal rabbit anti-cow
cytokeratin wide spectrum screening (WSS) antibody (Dako Corp., Carpinteria, CA). A
universal negative rabbit antibody (Dako Corp.) was used as the negative control reagent.
The primary antibody and negative control dilutions were prepared in 0.05 M Tris-HCl
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buffer, pH 7.0–7.6, containing 1% bovine serum albumin. After an overnight incubation
at 4°C, sections were washed with 0.05 M Tris-HCl buffer. Sections were incubated with
a ready-to-use goat anti-rabbit IgG, poly-HRP immunohistochemistry amplification
reagent (Chemicon International, Inc., Temecula, CA) for 1 hr at room temperature (20–
25ºC). After washing in 0.05 M Tris-HCl buffer (pH 7.0–7.6), sections were incubated
with the buffered substrate-DAB chromogen solution (Invitrogen Corp., Carlsbad, CA)
for 15 min, rinsed in deionized, diethylpyrocarbonate (DEPC)-treated H2O, and
counterstained with Mayer’s hematoxylin. In order to successfully capture trophoblasts,
sections were dehydrated in 75% , 95%, and 100% EtOH. Sections were then placed in
xylene until laser capture microdissection was performed.

Laser capture microdissection (LCM) to capture trophoblasts
Following immunohistochemical detection in placental specimens, trophoblasts
were microdissected using the Veritas™ Microdissection Instrument (Arcturus).
Microdissection was performed using the Capture IR laser (Power: 70 mW; Pulse: 2500
μsec; and Intensity: 200 mV) and UV Cutting laser (Laser spot size: ~8.0 μm and Laser
power: 7.0 mW). Similar sized cellular fields of ~2.00 mm2 were collected onto
CapSure Macro LCM Caps (Arcturus). All sections and capture areas were
photographed using the dissection instrument.
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Results
All H&E, IHC, and LCM results are shown in Figures 5.1–5.32. Routine
hematoxylin and eosin staining of the placental tissue produced the typical result, cells
with blue nuclei and pink cytoplasm. In addition, H&E staining of the placental tissue
provided confirmation that tissue integrity was not compromised during frozen storage.
IHC using the universal negative rabbit antibody and goat anti-rabbit IgG, poly-HRP IHC
amplification reagent did not result in intracellular staining. However, trophoblasts were
clearly identified after IHC staining with the polyclonal rabbit anti-cow cytokeratin wide
spectrum screening (WSS) antibody and goat anti-rabbit IgG, poly-HRP IHC
amplification reagent. Stained trophoblasts were demarcated and removed using laser
capture microdissection.
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Figure 5.1

Histological Evaluation and Immunohistochemical Localization of
Placental Trophoblasts from Early-Term FIV-negative Queen 2779
Placenta B

Placental tissues were cryosectioned to a thickness of 10 μm, fixed in acetone, and
dehydrated. Sections were stained with hematoxylin and eosin and photographed using
10X and 20X Veritas instrument objectives (A and B, respectively). Sections were
stained with a universal negative rabbit antibody and goat anti-rabbit IgG, poly-HRP
immunohistochemistry amplification reagent and photographed using 10X and 20X
Veritas instrument objectives (C and D, respectively). Sections were stained with the
polyclonal rabbit anti-cow cytokeratin WSS antibody and goat anti-rabbit IgG, poly-HRP
and photographed using the 20X Veritas instrument objective (E and F). Cytokeratinpositive trophoblasts are evident by the brown staining (E and F).
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Figure 5.2

Laser Capture Microdissection of IHC Stained Placental Trophoblasts
from Early-Term FIV-negative Queen 2779 Placenta B

Cytokeratin-positive placental trophoblasts are evident by the brown staining. (A)
Trophoblasts were selectively identified. (B) Areas of trophoblast-rich populations were
cut and captured using the UV cutting laser and Capture IR laser, respectively. (C)
Selected trophoblasts were removed from the tissue area. (D) Trophoblastic cells were
attached to the cap. (E and F) Cap images of acquired trophoblasts using the 2X Veritas
instrument objective. (A–D) Photography was performed with the 20X Veritas
instrument objective.
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Figure 5.3

Histological Evaluation and Immunohistochemical Localization of
Placental Trophoblasts from Early-Term FIV-negative Queen 2779
Placenta D

Placental tissues were cryosectioned to a thickness of 10 μm, fixed in acetone, and
dehydrated. Sections were stained with hematoxylin and eosin and photographed using
10X and 20X Veritas instrument objectives (A and B, respectively). Sections were
stained with a universal negative rabbit antibody and goat anti-rabbit IgG, poly-HRP
immunohistochemistry amplification reagent and photographed using 10X and 20X
Veritas instrument objectives (C and D, respectively). Sections were stained with the
polyclonal rabbit anti-cow cytokeratin WSS antibody and goat anti-rabbit IgG, poly-HRP
and photographed using the 20X Veritas instrument objective (E and F). Cytokeratinpositive trophoblastic cells are evident by the brown staining (E and F).
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Figure 5.4

Laser Capture Microdissection of IHC Stained Placental Trophoblasts
from Early-Term FIV-negative Queen 2779 Placenta D

Cytokeratin-positive placental trophoblasts are evident by the brown staining. (A)
Trophoblasts were selectively identified. (B) Areas of trophoblast-rich populations were
cut and captured using the UV cutting laser and Capture IR laser, respectively. (C)
Selected trophoblasts were removed from the tissue area. (D) Trophoblastic cells were
attached to the cap. (E and F) Cap images of acquired trophoblasts using the 2X Veritas
instrument objective. (A–D) Photography was performed with the 20X Veritas
instrument objective.
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Figure 5.5

Histological Evaluation and Immunohistochemical Localization of
Placental Trophoblasts from Early-Term FIV-negative Queen 2779
Resorption E

Placental tissues were cryosectioned to a thickness of 10 μm, fixed in acetone, and
dehydrated. Sections were stained with hematoxylin and eosin and photographed using
10X and 20X Veritas instrument objectives (A and B, respectively). Sections were
stained with a universal negative rabbit antibody and goat anti-rabbit IgG, poly-HRP
immunohistochemistry amplification reagent and photographed using 10X and 20X
Veritas instrument objectives (C and D, respectively). Sections were stained with the
polyclonal rabbit anti-cow cytokeratin WSS antibody and goat anti-rabbit IgG, poly-HRP
and photographed using the 20X Veritas instrument objective (E and F). Cytokeratinpositive trophoblastic cells are evident by the brown staining (E and F).
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Figure 5.6

Laser Capture Microdissection of IHC Stained Placental Trophoblasts
from Early-Term FIV-negative Queen 2779 Resorption E

Cytokeratin-positive placental trophoblasts are evident by the brown staining. (A)
Trophoblasts were selectively identified. (B) Areas of trophoblast-rich populations were
cut and captured using the UV cutting laser and Capture IR laser, respectively. (C)
Selected trophoblasts were removed from the tissue area. (D) Trophoblastic cells were
attached to the cap. All photography was performed with the 20X Veritas instrument
objective.
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Figure 5.7

Histological Evaluation and Immunohistochemical Localization of
Placental Trophoblasts from Early-Term FIV-positive Queen 0326
Placenta A

Placental tissues were cryosectioned to a thickness of 10 μm, fixed in acetone, and
dehydrated. Sections were stained with hematoxylin and eosin and photographed using
10X and 20X Veritas instrument objectives (A and B, respectively). Sections were
stained with a universal negative rabbit antibody and goat anti-rabbit IgG, poly-HRP
immunohistochemistry amplification reagent and photographed using 10X and 20X
Veritas instrument objectives (C and D, respectively). Sections were stained with the
polyclonal rabbit anti-cow cytokeratin WSS antibody and goat anti-rabbit IgG, poly-HRP
and photographed using the 10X and 20X Veritas instrument objectives (E and F,
respectively). Cytokeratin-positive trophoblastic cells are evident by the brown staining
(E and F).
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Figure 5.8

Laser Capture Microdissection of IHC Stained Placental Trophoblasts
from Early-Term FIV-positive Queen 0326 Placenta A

Cytokeratin-positive placental trophoblasts are evident by the brown staining. (A)
Trophoblasts were selectively identified. (B) Areas of trophoblast-rich populations were
cut and captured using the UV cutting laser and Capture IR laser, respectively. (C)
Selected trophoblasts were removed from the tissue area. (D) Trophoblastic cells were
attached to the cap. (E and F) Cap images of acquired trophoblasts using the 2X Veritas
instrument objective. (A–D) Photography was performed with the 20X Veritas
instrument objective.

100

Figure 5.9

Histological Evaluation and Immunohistochemical Localization of
Placental Trophoblasts from Early-Term FIV-positive Queen 8035
Arrested Placenta B

Placental tissues were cryosectioned to a thickness of 10 μm, fixed in acetone, and
dehydrated. Sections were stained with hematoxylin and eosin and photographed using
10X and 20X Veritas instrument objectives (A and B, respectively). Sections were
stained with a universal negative rabbit antibody and goat anti-rabbit IgG, poly-HRP
immunohistochemistry amplification reagent and photographed using 10X and 20X
Veritas instrument objectives (C and D, respectively). Sections were stained with the
polyclonal rabbit anti-cow cytokeratin WSS antibody and goat anti-rabbit IgG, poly-HRP
and photographed using the 20X Veritas instrument objective (E and F). Cytokeratinpositive trophoblastic cells are evident by the brown staining (E and F).
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Figure 5.10

Laser Capture Microdissection of IHC Stained Placental Trophoblasts
from Early-Term FIV-positive Queen 8035 Arrested Placenta B

Cytokeratin-positive placental trophoblasts are evident by the brown staining. (A)
Trophoblasts were selectively identified. (B) Areas of trophoblast-rich populations were
cut and captured using the UV cutting laser and Capture IR laser, respectively. (C)
Selected trophoblasts were removed from the tissue area. (D) Trophoblastic cells were
attached to the cap. (E and F) Cap images of acquired trophoblasts using the 2X Veritas
instrument objective. (A–D) Photography was performed with the 20X Veritas
instrument objective.
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Figure 5.11

Histological Evaluation and Immunohistochemical Localization of
Placental Trophoblasts from Early-Term FIV-positive Queen 8035
Arrested Placenta C

Placental tissues were cryosectioned to a thickness of 10 μm, fixed in acetone, and
dehydrated. Sections were stained with hematoxylin and eosin and photographed using
10X and 20X Veritas instrument objectives (A and B, respectively). Sections were
stained with a universal negative rabbit antibody and goat anti-rabbit IgG, poly-HRP
immunohistochemistry amplification reagent and photographed using 10X and 20X
Veritas instrument objectives (C and D, respectively). Sections were stained with the
polyclonal rabbit anti-cow cytokeratin WSS antibody and goat anti-rabbit IgG, poly-HRP
and photographed using the 20X Veritas instrument objective (E and F). Cytokeratinpositive trophoblastic cells are evident by the brown staining (E and F).
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Figure 5.12

Laser Capture Microdissection of IHC Stained Placental Trophoblasts
from Early-Term FIV-positive Queen 8035 Arrested Placenta C

Cytokeratin-positive placental trophoblasts are evident by the brown staining. (A)
Trophoblasts were selectively identified. (B) Areas of trophoblast-rich populations were
cut and captured using the UV cutting laser and Capture IR laser, respectively. (C)
Selected trophoblasts were removed from the tissue area. (D) Trophoblastic cells were
attached to the cap. (E) Cap image of acquired trophoblasts. (F) Tissue area remaining
after cellular extraction. (A–D) Photography was performed with the 20X Veritas
instrument objective. (E and F) Photography was performed with the 2X Veritas
instrument objective.
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Figure 5.13

Histological Evaluation and Immunohistochemical Localization of
Placental Trophoblasts from Early-Term FIV-positive Queen 0866
Placenta A

Placental tissues were cryosectioned to a thickness of 10 μm, fixed in acetone, and
dehydrated. Sections were stained with hematoxylin and eosin and photographed using
10X and 20X Veritas instrument objectives (A and B, respectively). Sections were
stained with a universal negative rabbit antibody and goat anti-rabbit IgG, poly-HRP
immunohistochemistry amplification reagent and photographed using 10X and 20X
Veritas instrument objectives (C and D, respectively). Sections were stained with the
polyclonal rabbit anti-cow cytokeratin WSS antibody and goat anti-rabbit IgG, poly-HRP
and photographed using the 20X Veritas instrument objective (E and F). Cytokeratinpositive trophoblastic cells are evident by the brown staining (E and F).
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Figure 5.14

Laser Capture Microdissection of IHC Stained Placental Trophoblasts
from Early-Term FIV-positive Queen 0866 Placenta A

Cytokeratin-positive placental trophoblasts are evident by the brown staining. (A)
Trophoblasts were selectively identified. (B) Areas of trophoblast-rich populations were
cut and captured using the UV cutting laser and Capture IR laser, respectively. (C)
Selected trophoblasts were removed from the tissue area. (D) Trophoblastic cells were
attached to the cap. (E) Cap image of acquired trophoblasts using the 2X Veritas
instrument objective. (A–D) Photography was performed with the 20X Veritas
instrument objective.
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Figure 5.15

Histological Evaluation and Immunohistochemical Localization of
Placental Trophoblasts from Early-Term FIV-positive Queen 0866
Placenta B Resorption

Placental tissues were cryosectioned to a thickness of 10 μm, fixed in acetone, and
dehydrated. Sections were stained with hematoxylin and eosin and photographed using
10X and 20X Veritas instrument objectives (A and B, respectively). Sections were
stained with a universal negative rabbit antibody and goat anti-rabbit IgG, poly-HRP
immunohistochemistry amplification reagent and photographed using 10X and 20X
Veritas instrument objectives (C and D, respectively). Sections were stained with the
polyclonal rabbit anti-cow cytokeratin WSS antibody and goat anti-rabbit IgG, poly-HRP
and photographed using the 20X Veritas instrument objective (E and F). Cytokeratinpositive trophoblastic cells are evident by the brown staining (E and F).
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Figure 5.16

Laser Capture Microdissection of IHC Stained Placental Trophoblasts
from Early-Term FIV-positive Queen 0866 Placenta B Resorption

Cytokeratin-positive placental trophoblasts are evident by the brown staining. (A)
Trophoblasts were selectively identified. (B) Areas of trophoblast-rich populations were
cut and captured using the UV cutting laser and Capture IR laser, respectively. (C)
Selected trophoblasts were removed from the tissue area. (D) Trophoblastic cells were
attached to the cap. (E) Cap image of acquired trophoblasts. (F) Tissue area remaining
after cellular extraction. (A–D) Photography was performed with the 20X Veritas
instrument objective. (E and F) Photography was performed with the 2X Veritas
instrument objective.

108

Figure 5.17

Histological Evaluation and Immunohistochemical Localization of
Placental Trophoblasts from Late-Term FIV-negative Queen 9581
Placenta A

Placental tissues were cryosectioned to a thickness of 10 μm, fixed in acetone, and
dehydrated. Sections were stained with hematoxylin and eosin and photographed using
10X and 20X Veritas instrument objectives (A and B, respectively). Sections were
stained with a universal negative rabbit antibody and goat anti-rabbit IgG, poly-HRP
immunohistochemistry amplification reagent and photographed using 10X and 20X
Veritas instrument objectives (C and D, respectively). Sections were stained with the
polyclonal rabbit anti-cow cytokeratin WSS antibody and goat anti-rabbit IgG, poly-HRP
and photographed using the 20X Veritas instrument objective (E). Cytokeratin-positive
trophoblastic cells are evident by the brown staining (E) .
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Figure 5.18

Laser Capture Microdissection of IHC Stained Placental Trophoblasts
from Late-Term FIV-negative Queen 9581 Placenta A

Cytokeratin-positive placental trophoblasts are evident by the brown staining. (A)
Trophoblasts were selectively identified. (B) Areas of trophoblast-rich populations were
cut and captured using the UV cutting laser and Capture IR laser, respectively. (C)
Selected trophoblasts were removed from the tissue area. (D) Trophoblastic cells were
attached to the cap. All photography was performed with the 20X Veritas instrument
objective.
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Figure 5.19

Histological Evaluation and Immunohistochemical Localization of
Placental Trophoblasts from Late-Term FIV-negative Queen 9581
Placenta B

Placental tissues were cryosectioned to a thickness of 10 μm, fixed in acetone, and
dehydrated. Sections were stained with hematoxylin and eosin and photographed using
10X and 20X Veritas instrument objectives (A and B, respectively). Sections were
stained with a universal negative rabbit antibody and goat anti-rabbit IgG, poly-HRP
immunohistochemistry amplification reagent and photographed using 10X and 20X
Veritas instrument objectives (C and D, respectively). Sections were stained with the
polyclonal rabbit anti-cow cytokeratin WSS antibody and goat anti-rabbit IgG, poly-HRP
and photographed using the 20X Veritas instrument objective (E and F). Cytokeratinpositive trophoblastic cells are evident by the brown staining (E and F).
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Figure 5.20

Laser Capture Microdissection of IHC Stained Placental Trophoblasts
from Late-Term FIV-negative Queen 9581 Placenta B

Cytokeratin-positive placental trophoblasts are evident by the brown staining. (A)
Trophoblasts were selectively identified. (B) Areas of trophoblast-rich populations were
cut and captured using the UV cutting laser and Capture IR laser, respectively. (C)
Selected trophoblasts were removed from the tissue area. (D) Trophoblastic cells were
attached to the cap. (E and F) Cap images of acquired trophoblasts using the 2X Veritas
instrument objective. (A–D) Photography was performed with the 20X Veritas
instrument objective.
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Figure 5.21

Histological Evaluation and Immunohistochemical Localization of
Placental Trophoblasts from Late-Term FIV-negative Queen 9746
Placenta C

Placental tissues were cryosectioned to a thickness of 10 μm, fixed in acetone, and
dehydrated. Sections were stained with hematoxylin and eosin and photographed using
10X and 20X Veritas instrument objectives (A and B, respectively). Sections were
stained with a universal negative rabbit antibody and goat anti-rabbit IgG, poly-HRP
immunohistochemistry amplification reagent and photographed using 10X and 20X
Veritas instrument objectives (C and D, respectively). Sections were stained with the
polyclonal rabbit anti-cow cytokeratin WSS antibody and goat anti-rabbit IgG, poly-HRP
and photographed using the 20X Veritas instrument objective (E and F). Cytokeratinpositive trophoblastic cells are evident by the brown staining (E and F).
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Figure 5.22

Laser Capture Microdissection of IHC Stained Placental Trophoblasts
from Late-Term FIV-negative Queen 9746 Placenta C

Cytokeratin-positive placental trophoblasts are evident by the brown staining. (A)
Trophoblasts were selectively identified. (B) Areas of trophoblast-rich populations were
cut and captured using the UV cutting laser and Capture IR laser, respectively. (C)
Selected trophoblasts were removed from the tissue area. (D) Trophoblastic cells were
attached to the cap. All photography was performed with the 20X Veritas instrument
objective.
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Figure 5.23

Histological Evaluation and Immunohistochemical Localization of
Placental Trophoblasts from Late-Term FIV-positive Queen 9730
Placenta B

Placental tissues were cryosectioned to a thickness of 10 μm, fixed in acetone, and
dehydrated. Sections were stained with hematoxylin and eosin and photographed using
10X and 20X Veritas instrument objectives (A and B, respectively). Sections were
stained with a universal negative rabbit antibody and goat anti-rabbit IgG, poly-HRP
immunohistochemistry amplification reagent and photographed using 10X and 20X
Veritas instrument objectives (C and D, respectively). Sections were stained with the
polyclonal rabbit anti-cow cytokeratin WSS antibody and goat anti-rabbit IgG, poly-HRP
and photographed using the 20X Veritas instrument objective (E and F). Cytokeratinpositive trophoblastic cells are evident by the brown staining (E and F).
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Figure 5.24

Laser Capture Microdissection of IHC Stained Placental Trophoblasts
from Late-Term FIV-positive Queen 9730 Placenta B

Cytokeratin-positive placental trophoblasts are evident by the brown staining. (A)
Trophoblasts were selectively identified. (B) Areas of trophoblast-rich populations were
cut and captured using the UV cutting laser and Capture IR laser, respectively. (C)
Selected trophoblasts were removed from the tissue area. (D) Trophoblastic cells were
attached to the cap. (E and F) Cap images of acquired trophoblasts using the 2X Veritas
instrument objective. (A–D) Photography was performed with the 20X Veritas
instrument objective.
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Figure 5.25

Histological Evaluation and Immunohistochemical Localization of
Placental Trophoblasts from Late-Term FIV-positive Queen 9730
Placenta Resorption 1

Placental tissues were cryosectioned to a thickness of 10 μm, fixed in acetone, and
dehydrated. Sections were stained with hematoxylin and eosin and photographed using
10X and 20X Veritas instrument objectives (A and B, respectively). Sections were
stained with a universal negative rabbit antibody and goat anti-rabbit IgG, poly-HRP
immunohistochemistry amplification reagent and photographed using 10X and 20X
Veritas instrument objectives (C and D, respectively). Sections were stained with the
polyclonal rabbit anti-cow cytokeratin WSS antibody and goat anti-rabbit IgG, poly-HRP
and photographed using the 20X Veritas instrument objective (E and F). Cytokeratinpositive trophoblastic cells are evident by the brown staining (E and F).
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9730 resorb 1
Figure 5.26

Laser Capture Microdissection of IHC Stained Placental Trophoblasts
from Late-Term FIV-positive Queen 9730 Placenta Resorption 1

Cytokeratin-positive placental trophoblasts are evident by the brown staining. (A)
Trophoblasts were selectively identified. (B) Areas of trophoblast-rich populations were
cut and captured using the UV cutting laser and Capture IR laser, respectively. (C)
Selected trophoblasts were removed from the tissue area. (D) Trophoblastic cells were
attached to the cap. (E and F) Cap images of acquired trophoblasts using the 2X Veritas
instrument objective. (A–D) Photography was performed with the 20X Veritas
instrument objective.
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Figure 5.27

Histological Evaluation and Immunohistochemical Localization of
Placental Trophoblasts from Late-Term FIV-positive Queen 9730
Placenta Resorption 3

Placental tissues were cryosectioned to a thickness of 10 μm, fixed in acetone, and
dehydrated. Sections were stained with hematoxylin and eosin and photographed using
10X and 20X Veritas instrument objectives (A and B, respectively). Sections were
stained with a universal negative rabbit antibody and goat anti-rabbit IgG, poly-HRP
immunohistochemistry amplification reagent and photographed using 10X and 20X
Veritas instrument objectives (C and D, respectively). Sections were stained with the
polyclonal rabbit anti-cow cytokeratin WSS antibody and goat anti-rabbit IgG, poly-HRP
and photographed using the 20X Veritas instrument objective (E and F). Cytokeratinpositive trophoblastic cells are evident by the brown staining (E and F).
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Figure 5.28

Laser Capture Microdissection of IHC Stained Placental Trophoblasts
from Late-Term FIV-positive Queen 9730 Placenta Resorption 3

Cytokeratin-positive placental trophoblasts are evident by the brown staining. (A)
Trophoblasts were selectively identified. (B) Areas of trophoblast-rich populations were
cut and captured using the UV cutting laser and Capture IR laser, respectively. (C)
Selected trophoblasts were removed from the tissue area. (D) Trophoblastic cells were
attached to the cap. (E and F) Cap images of acquired trophoblasts using the 2X Veritas
instrument objective. (A–D) Photography was performed with the 20X Veritas
instrument objective.
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Figure 5.29

Histological Evaluation and Immunohistochemical Localization of
Placental Trophoblasts from Late-Term FIV-positive Queen 13226
Arrested Placenta 3

Placental tissues were cryosectioned to a thickness of 10 μm, fixed in acetone, and
dehydrated. Sections were stained with hematoxylin and eosin and photographed using
10X and 20X Veritas instrument objectives (A and B, respectively). Sections were
stained with a universal negative rabbit antibody and goat anti-rabbit IgG, poly-HRP
immunohistochemistry amplification reagent and photographed using the 20X Veritas
instrument objective (C). Sections were stained with the polyclonal rabbit anti-cow
cytokeratin WSS antibody and goat anti-rabbit IgG, poly-HRP and photographed using
the 20X Veritas instrument objective (D). Cytokeratin-positive trophoblastic cells are
evident by the brown staining (D).

121

Figure 5.30

Laser Capture Microdissection of IHC Stained Placental Trophoblasts
from Late-Term FIV-positive Queen 13226 Arrested Placenta 3

Cytokeratin-positive placental trophoblasts are evident by the brown staining. (A)
Trophoblasts were selectively identified and areas of trophoblast-rich populations were
cut and captured using the UV cutting laser and Capture IR laser, respectively. (B)
Selected trophoblasts were removed from the tissue area. (C) Trophoblastic cells were
attached to the cap. (D–F) Cap images of acquired trophoblasts using the 2X Veritas
instrument objective. (A–C) Photography was performed with the 20X Veritas
instrument objective.
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Figure 5.31

Histological Evaluation and Immunohistochemical Localization of
Placental Trophoblasts from Late-Term FIV-positive Queen 13226
Arrested Placenta 4

Placental tissues were cryosectioned to a thickness of 10 μm, fixed in acetone, and
dehydrated. Sections were stained with hematoxylin and eosin and photographed using
10X and 20X Veritas instrument objectives (A and B, respectively). Sections were
stained with a universal negative rabbit antibody and goat anti-rabbit IgG, poly-HRP
immunohistochemistry amplification reagent and photographed using the 20X Veritas
instrument objective (C). Sections were stained with the polyclonal rabbit anti-cow
cytokeratin WSS antibody and goat anti-rabbit IgG, poly-HRP and photographed using
the 10X Veritas instrument objective (D). Cytokeratin-positive trophoblastic cells are
evident by the brown staining (D).
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Figure 5.32

Laser Capture Microdissection of IHC Stained Placental Trophoblasts
from Late-Term FIV-positive Queen 13226 Arrested Placenta 4

Cytokeratin-positive placental trophoblasts are evident by the brown staining. (A)
Trophoblasts were selectively identified. (B) Areas of trophoblast-rich populations were
cut and captured using the UV cutting laser and Capture IR laser, respectively. (C)
Selected trophoblasts were removed from the tissue area. (D) Trophoblastic cells were
attached to the cap. (E and F) Cap images of acquired trophoblasts using the 2X Veritas
instrument objective. (A–D) Photography was performed with the 10X Veritas
instrument objective.
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Conclusion
Similar to HIV, FIV infections may cause dysregulation of trophoblastic cytokine
expression, and aberrant expression of these cytokines may potentiate inflammation and
transplacental infections. Although an early report by our lab indicated that
inflammatory cytokine expression is upregulated in placentas where reproductive failure
occurred, the specific cell populations expressing the cytokines were not identified
(Weaver et al., 2005). Here we report that hematoxylin and eosin staining of FIV-B2542-infected and non-infected samples resulted in stained cells with blue nuclei and
pink cytoplasm and confirmed that tissue integrity was not compromised during frozen
storage. Trophoblastic cells were selectively identified in all placental samples using
immunohistochemistry. Trophoblastic cells were demarcated and removed using laser
capture microdissection. Future studies will involve nucleic acid extraction from
collected trophoblastic cells. This nucleic acid will be used in real-time RT-PCR to
measure gene expression.
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CHAPTER VI
IMMUNOMODULATOR EXPESSION IN TROPHOBLASTS FROM THE
FIV-INFECTED CAT

Abstract
Maternal-fetal transmission of the feline immunodeficiency virus (FIV) occurs
commonly in queens experimentally infected with FIV-B-2542. Fetal infection with FIV
has been detected by 3–4 weeks gestation. Reproductive failure frequently occurs in the
FIV-infected cat, resulting in resorptions or developmentally-arrested fetuses. The
incidence of reproductive failure in the FIV-infected cat parallels the incidence of
spontaneous abortion in HIV-infected women. Immune homeostasis of cytokines and
chemokines in the placenta is necessary for successful pregnancy. Successful pregnancy
is typically biased towards a Th2 humoral immune response (anti-inflammatory) with a
suppressed Th1 cell-mediated immune response (pro-inflammatory) at the maternal-fetal
interface. Dysregulation of cytokines during pregnancy often results in fetal death.
Placental trophoblasts produce cytokines and chemokines that modulate pregnancy and
may play a role in maternal tolerance of embryo and fetal allografts. We hypothesized
that FIV infections may cause dysregulation of trophoblastic cytokine expression, and
aberrant expression of these cytokines may potentiate inflammation and transplacental
infections. The purpose of this project was to quantify the expression of Th1 cytokines
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(TNF-α, IFN-γ, IL-1β, IL-2, IL-12p35, IL-12p40, and IL-18), the Th2 cytokines (IL-4,
IL-5, IL-6, and IL-10), the cytokine GM-CSF, the primary FIV receptor CD134, the
chemokine SDF-1α, the chemokine receptor CXCR4, and FIV gag in placental
trophoblasts from early- and late-term pregnancy. We used a cytokeratin marker in
immunohistochemistry to selectively identify trophoblastic cellular populations.
Identified trophoblastic cells were collected using laser capture microdissection and total
RNA was extracted from the captured cell populations. Reverse transcription-PCR was
used to amplify cDNA from the RNA samples. Real-time quantitative PCR was used to
measure gene expression. We were able to detect only IL-4, IL-5, IL-6, IL-1β, IL-12p35,
IL-12p40, and CXCR4 in feline placental trophoblasts from early- and late-term
pregnancy. We found expression of pro- and anti-inflammatory cytokines at both time
points during gestation. We report increased immune function of trophoblasts late in
pregnancy. While we did not find that increased expression of pro-inflammatory
cytokines accompanied reproductive failure, FIV-infection did alter expression of some
cytokines in trophoblasts, and reproductive failure was accompanied by down-regulation
of both pro- and anti-inflammatory cytokines. FIV gag was detected in only one
trophoblast specimen, and CD134 was not detected. Thus, feline placental trophoblasts
do not appear to be easily infected by FIV and trophoblastic immunomodulation is
influenced by the surrounding placental microenvironment rather than direct viral
infection.
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Introduction
Globally, the estimated number of people living with HIV is 33.4 million, 2.1
million of which are children (UNAIDS/WHO, 2009a). The pediatric AIDS pandemic
causes 1,200 new HIV infections daily (UNAIDS/WHO, 2009a), with mother-to-child
transmission (MTCT) of the virus accounting for 90% of pediatric infections (CDC,
2008). In the United States, MTCT is the most common cause of pediatric AIDS cases
(defined as AIDS occurring in children under the age of 13 years) and results in 100–200
infected infants annually (CDC, 2007). Children who are infected in utero have a more
rapid progression to AIDS and generally become symptomatic during the first year of
life. In the absence of antiviral treatment, 50% of HIV-infected newborns will succumb
to the disease before 24 months of age (UNAIDS/WHO, 2009b). Moreover,
transplacental transfer of HIV results in poor reproductive outcomes, including low birth
weight babies, preterm delivery, and an increased incidence of spontaneous abortions
(D'Ubaldo et al., 1998; Kumar et al., 1995; Langston et al., 1995). Although HIV has the
potential to negatively impact fetal and neonatal health, the mechanisms of HIV vertical
transmission and pregnancy perturbation associated with infection remain undefined.
Immunoregulatory molecules such as cytokines and chemokines are responsible
for pregnancy maintenance and aid in the maternal tolerance of embryo and fetal
allografts and the regulation of maternal cell-mediated and humoral immune responses
against infection (Bennett et al., 1998; Challis et al., 2009; Clark and Chaouat, 1989;
Robertson et al., 1994; Saito, 2001). Successful pregnancy is typically biased towards a
Th2 humoral immune response (anti-inflammatory) with a suppressed Th1 cell-mediated
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immune response (pro-inflammatory) at the maternal-fetal interface (Challis et al., 2009;
Costeas et al., 2004; Raghupathy, 1997; Wegmann et al., 1993). Due to the mutually
antagonistic nature of Th1 and Th2 cytokines, an inflammatory microenvironment in the
placenta is prevented with enhanced humoral immunity during early pregnancy (Challis
et al., 2009; Mosmann and Coffman, 1989; Wegmann et al., 1993). However, the
balance of cytokines is shifted during late pregnancy and a Th1 immune response
dominates to initate labor and the expulsion of the fetus and fetal membranes. A clear
indicator of Th1:Th2 immune shifts is the altered expression of the Th1 cytokine, IL-12
(a pro-inflammatory cytokine), and the Th2 cytokine, IL-10 (an anti-inflammatory
cytokine). Moreover, the altered expression of Th1 and Th2 cytokines during pregnancy
may result in cytokine dysregulation (Challis et al., 2009; Costeas et al., 2004;
Romagnani, 1994; Wegmann et al., 1993). Cytokine dysregulation in the placenta may
compromise pregnancy and cause fetal death (Challis et al., 2009; Orsi and Tribe, 2008).
During gestation, Th1 and Th2 cytokines are produced in the decidual epithelium
and stroma, chorionic and amnionic membranes, and trophoblastic cells (Wilczynski,
2005). Placental trophoblastic cells (cytotrophoblasts and syncytiotrophoblasts) are fetalderived cells of epithelial origin that form the placental chorionic villi. These
trophoblastic cells contact and form attachment with the maternal endometrium and serve
as a barrier between maternal and fetal blood supplies in human pregnancy (Lagaye et al.,
2001). Vertical transfer of HIV likely results in productive viral infection of these
trophoblast layers (Douglas et al., 1991; Vidricaire et al., 2003). The expression of HIV
is augmented by placental cytokines and chemokines (Kedzierska and Crowe, 2001), and
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HIV infections can dysregulate cytokine networks in placental tissues (Lee et al., 1997;
Shearer et al., 1997). Aberrant expression of cytokines may result in placental
inflammation, and the presence of inflamed placental membranes is likely to facilitate
viral transplacental transfer (Shearer et al., 1997).
The feline immunodeficiency virus (FIV) causes a natural retroviral infection of
domestic cats with a clinical course of infection similar to that of HIV. Feline AIDS is
characterized by progressive depletion of CD4+ T cells culminating in fatal opportunistic
infections. Vertical transmission of FIV occurs commonly under experimental
conditions, resulting in viable and non-viable infected offspring (Allison and Hoover,
2003; Boudreaux et al., 2009; Weaver et al., 2005), similar to pregnancy outcome in
HIV-infected women. Therefore, the FIV-infected cat is a useful small animal model for
the study of lentiviral transplacental transfer.
Using the FIV-infected cat model, we demonstrated frequent reproductive failure
in litters delivered at early- and late-gestation by cesarean section (Boudreaux et al.,
2009; Weaver et al., 2005). Placental and fetal infection occurred in nearly all FIVinfected pregnancies, and fetal non-viability was frequent and appeared to occur during
early pregnancy. Th1 and Th2 cytokine expression did not differ significantly in the lateterm placentas of infected and uninfected cats, although the trend was toward increased
expression of Th1 cytokines (IFN-γ and IL-1β) and decreased expression of the Th2
cytokine (IL-10). Th1 cytokine expression was significantly increased in placentas from
FIV-infected, resorbed fetuses in comparison to other placentas. Early-term placentas
were not evaluated in that study (Weaver et al., 2005).
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In Chapter III, we reported that FIV-infection during early- and late-term
gestation affects immunomodulator expression. However, the specific cell populations
expressing the targeted immunomodulators were not identified. In the present study, we
hypothesized that FIV infections may cause dysregulation of trophoblastic cytokine
expression, and aberrant expression of these cytokines may potentiate inflammation and
transplacental infections. Our objective was to quantify the expression of Th1 cytokines
(TNF-α, IFN-γ, IL-1β, IL-2, IL-12p35, IL-12p40, and IL-18), the Th2 cytokines (IL-4,
IL-5, IL-6, and IL-10), the cytokine GM-CSF, the primary FIV receptor CD134, the
chemokine SDF-1α, the chemokine receptor CXCR4, and FIV gag in trophoblasts
microdissected from early- and late-term placental tissues. We were able to detect only
IL-4, IL-5, IL-6, IL-1β, IL-12p35, IL-12p40, and CXCR4 in feline placental trophoblasts
from early- and late-term pregnancy. We report altered trophoblast function late in
pregnancy. We did not detect expression of the FIV primary receptor CD134 and our
failure to detect FIV gag indicated that trophoblasts were not infected by the virus.
Therefore, aberrant trophoblast function is most likely a result of an altered
microenvironment occurring in FIV-infected placental tissue surrounding the
trophoblasts, rather than a direct consequence of trophoblast infection.
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Materials and Methods

Animals and virus
All procedures utilizing cats (Felis domesticus) were performed with approval of
the Mississippi State University Institutional Animal Care and Use Committee. As
previously reported (Boudreaux et al., 2009; Weaver et al., 2005), cats were
reproductively mature, specific-pathogen-free (SPF) animals of less than 12 months of
age when obtained from a commercial cattery. Ten cats were inoculated intravenously
with 1 ml of a feline plasma pool containing approximately 1.33 x 104 copies/ml of FIVB-2542 originally provided by Dr. Edward Hoover (Rogers and Hoover, 1998). Ten cats
were sham inoculated with 1 ml of pooled uninfected plasma and served as normal
controls. Infection was confirmed within 6 weeks p.i. by detection of FIV provirus by
PCR and for seroconversion using the PetChek® FIV Antibody Test Kit (IDEXX
Laboratories, Inc., Westbrook, ME). All queens were allowed to naturally breed with
SPF toms. Toms used to breed uninfected females were never exposed to infected
females and vice versa. Breeding was observed and pregnancy was confirmed by
palpation and ultrasonography.
Kittens were delivered by cesarean section during week 3 gestation (early-term)
(Boudreaux et al., 2009) and week 8 gestation (late-term) (Weaver et al., 2005).
Placentas were collected under sterile conditions using the following dissection
procedure. The uteri were removed and individual gestational sacs were collected.
Following rinses with sterile PBS, sacs were incised with a sterile scalpel, and fetuses and
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placentas were collected. Placental tissues were snap frozen in liquid nitrogen and
cryopreserved at -80°C. The effect of FIV infection on fetal viability at early- and lateterm pregnancy was previously reported (Boudreaux et al., 2009; Weaver et al., 2005).
For this study, we evaluated eight selected placental samples from both early- and lateterm gestation, including placentas from viable and non-viable pregnancies. Due to the
poor placental development at 3 weeks gestation, placentas from early-term pregnancies
were collected from tissue connecting the embryo to the umbilical cord. All placental
tissues used in this study are listed in Table 6.1

Immunohistochemistry (IHC) to detect trophoblasts
All IHC procedures were performed using RNase-free, sterile conditions. Snap
frozen placental tissues were embedded in OCT, sectioned to a thickness of 10 μm using
a cryostat, and placed on RNase-free glass membrane slides (Molecular Devices,
Sunnyvale, CA). Sections were fixed with acetone at room temperature (20–25ºC).
Endogenous peroxidase activity in dehydrated sections was quenched with 400 ml
methanol / 2 ml 30% H2O2 solution. Quenched sections were washed in 0.05 M Tris-HCl
buffer (TB) (pH 7.0–7.6). To prevent non-specific antibody binding, sections were
blocked with 5% (w/v) non-fat dry milk in TB (Blotto) and washed in 0.05 M Tris-HCl
buffer (pH 7.0–7.6). Trophoblastic cells were stained with a polyclonal rabbit anti-cow
cytokeratin wide spectrum screening (WSS) antibody (Dako Corp., Carpinteria, CA). A
universal negative rabbit antibody (Dako Corp.) was used as the negative control reagent.
The primary antibody and negative control dilutions were prepared in 0.05 M Tris-HCl
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buffer, pH 7.0–7.6, containing 1% bovine serum albumin. After an overnight incubation
at 4°C, sections were washed with 0.05 M Tris-HCl buffer. Sections were incubated with
a ready-to-use goat anti-rabbit IgG, poly-HRP immunohistochemistry amplification
reagent (Chemicon International, Inc., Temecula, CA) for 1 hr at room temperature (20–
25ºC). After washing in 0.05 M Tris-HCl buffer (pH 7.0–7.6), sections were incubated
with the buffered substrate-DAB chromogen solution (Invitrogen Corp., Carlsbad, CA)
for 15 min, rinsed in deionized, diethylpyrocarbonate (DEPC)-treated H2O, and
counterstained with Mayer’s hematoxylin. To successfully capture trophoblastic cells,
sections were dehydrated in 75% , 95%, and 100% EtOH. Sections were then placed in
xylene until laser capture microdissection was performed.

Laser capture microdissection (LCM) to capture trophoblasts
Following immunohistochemical detection in placental specimens, trophoblasts
were microdissected using the Veritas™ Microdissection Instrument (Arcturus
Bioscience, Inc., MountainView, CA). Microdissection was performed using the Capture
IR laser (Power: 70 mW; Pulse: 2500 μsec; and Intensity: 200 mV) and UV Cutting
laser (Laser spot size: ~8.0 μm and Laser power: 7.0 mW). Similar-sized cellular fields
of ~2.00 mm2 were collected onto CapSure Macro LCM Caps (Arcturus). All sections
and capture areas were photographed using the dissection instrument (Chapter V).
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RNA purification and quantification from microdissected tissues
RNA was extracted from microdissected trophoblastic cells of FIV-B-2542infected and uninfected queens at early gestation (n = 5 and n = 3, respectively) and late
gestation (n = 5 and n = 3, respectively), using the PicoPure RNA Isolation Kit
(Arcturus). All RNA samples were treated with DNase to remove contaminating
genomic DNA. RNA was quantified using the NanoDrop™ 3300 Fluorospectrometer
(Thermo Fisher Scientific, Inc. Waltham, MA). All RNA was stored at -80°C until use.

Reverse transcription-polymerase chain reaction (RT-PCR) to generate cDNA
Reverse transcription-polymerase chain reaction (RT-PCR) used a MJ Mini
Personal Thermal Cycler (Bio-Rad Laboratories, Inc., Hercules, CA): 25°C, 10 min;
37°C, 120 min; 85°C, 5 sec; 4°C, hold. cDNA was synthesized using the High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems, Inc., Foster City, CA) according
to the manufacturer’s instructions. Briefly, each reverse transcription reaction was
performed in a final reaction volume of 20 μl containing 2 μl of the 10X RT buffer and
RT random primers, 0.8 μl of 25X dNTP, 1 μl of Multiscribe Reverse Transcriptase and
RNase inhibitor, 3.2 μl of RNase-free water, and 10 μl of ~30–800 pg RNA template. All
cDNA was stored at -20°C until use.

Primer design of feline immunomodulators, FIV receptors, and the internal control
All primer design methods were previously reported (Scott et al., 2008) and
sequences of PCR primers and TaqMan probes specific for feline immunomodulators,
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FIV receptors, and the internal control mRNA are listed in Table A.1. All reference
feline primers and probes used in this study are listed in Table A.2.

Evaluation of expression of immunomodulators using TaqMan real-time PCR
The real-time PCR (rtPCR) used an iCycler (Bio-Rad): 50°C, 2 min; 95°C, 10
min; 60 X (95°C, 15 s; 60°C, 1 min). Each reaction contained 10 μl of the 2X TaqMan®
Universal PCR Master Mix (Applied Biosystems), 1 μl of forward and reverse primers
(10 pmol/μl), 1 μl of the respective probe (100 fmol/μl), and ~2–4 μg cDNA. For every
placental cDNA sample, parallel reactions were performed in triplicate simplex reactions
on separate plates for each gene. Due to the paucity of cDNA concentrations associated
with cellular extractions, serially-diluted and pooled whole tissue RNA from
representative uninfected cats (Chapter III) was used to generate standard curves for the
internal control and target gene amplicons. Each titration simplex reaction contained
6.25 μl of the 2X Thermoscript™ reaction mix, 0.25 μl of Thermoscript™ RT/Platinum®
Taq Mix (Invitrogen), 1 μl of forward and reverse primers (10 pmol/μl), 1 μl of the
respective probe (100 fmol/μl), and five-fold diluted 2 μg RNA as starting titration
template. The standard curves were used to normalize for differences in PCR efficiency
between the internal control and target genes and between sample plate runs. Differences
in the amount of template cDNA in each reaction was corrected by the cycle threshold
(Ct) value for β-actin. Normalized samples were divided by the calibration, generating
the relative expression levels.
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Statistical analysis
Statistical evaluation of fetal viability from early- and late-term gestation were
previously reported (Boudreaux et al., 2009; Weaver et al., 2005). Statistical analysis of
immunomodulator expression for early- and late-term control and FIV-B-2542-infected
trophoblasts were done using single-factor ANOVA (Microsoft Excel-XP, Redmond,
WA) followed by the two independent sample Wilcoxon rank sum test (SOCR Analysis,
University of California, Los Angeles, CA) .

Results

Expression of immunomodulators in placental trophoblasts
Immunomodulator mRNAs for IL-4, IL-5, IL-6, IL-1β, IL-12p35, IL-12p40, and
CXCR4 were expressed in all early- and late-term placental trophoblasts. We were
unable to detect TNF-α, IFN-γ, IL-2, IL-18, IL-10, GM-CSF, CD134, and SDF-1α in
trophoblasts from either stage of pregnancy. We detected Gag in only one late-term
trophoblastic sample that was associated with a fetal resorption (Fig. 6.1).
To determine normal feline placental trophoblastic expression of the detected
immunomodulators between the two stages of pregnancy, data obtained from control
placentas from early- and late-term were compared. There were significant differences in
expression of all immunomodulators except IL-5 (p = 0.135) in control placental
trophoblasts between the two stages of pregnancy. Trophoblasts from control cats at late
gestation expressed more IL-4 (p = 0.025), IL-6 (p = 1.36E-08), IL-1β (p = 0.001),
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IL-12p35 (p = 0.001), IL-12p40 (p = 0.002), and CXCR4 (p = 0.006) mRNA than
trophoblasts from early gestation (Fig. 6.2).
To determine the effect of FIV infection on placental trophoblastic cytokine
expression, FIV-infected and control trophoblasts from both early- and late-term
gestation were compared. At early gestation, FIV-infection resulted in decreased
expression of the anti-inflammatory cytokine IL-5 (p = 0.038) mRNA and had no effect
on the mRNA expression of the anti-inflammatory cytokine IL-4 (p = 0.335), the proinflammatory cytokines IL-6 (p = 0.276), IL-1β (p = 0.096), IL-12p35 (p = 0.060),
IL-12p40 (p = 0.319), or the chemokine receptor CXCR4 (p = 0.199) (Fig. 6.3). At late
gestation, FIV-infection resulted in decreased mRNA expression of the anti-inflammatory
cytokine IL-4 (p = 0.021) and the pro-inflammatory cytokine IL-12p35 (p = 0.021) and
had no effect on the mRNA expression of IL-5 (p = 0.0135), IL-6 (p = 0.178), IL-1β (p =
0.108), and CXCR4 (p = 0.111) (Fig. 6.4). Decreased expression of the proinflammatory cytokine IL-12p40 (p = 0.057) approached significance (Fig. 6.4).
To determine whether cytokine expression was related to fetal viability, placental
trophoblasts from FIV-infected, viable pregnancies were compared to trophoblasts from
FIV-infected, non-viable pregnancies for early-term gestation. Due to the low
concentration of trophoblast RNA associated with microdissection and subsequent lack of
detection of some cytokine mRNA in some infected viable and infected non-viable
trophoblasts, we were unable to statistically compare infected, viable trophoblasts to
infected, non-viable trophoblasts for late-term gestation. In addition, we were only able
to make statistical comparisons of IL-4, IL-5, IL-6, IL-1β, and IL-12p35 for early-term
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infected, viable and infected, non-viable trophoblasts. At early gestation, there were no
significant differences in immunomodulator expression when trophoblasts from infected,
viable pregnancies were compared to trophoblasts from infected, non-viable pregnancies
(Fig. 6.5).
To determine whether cytokine expression was related to fetal viability,
regardless of infection, trophoblasts from all viable pregnancies were compared to
trophoblasts from all non-viable pregnancies for both early- and late-term gestation. At
early gestation, trophoblasts from non-viable pregnancies expressed significantly less
IL-4 (p = 0.032), IL-6 (p = 0.048), IL-12p35 (p = 0.001), and CXCR4 (p = 0.004) mRNA
than those of viable pregnancies. The decreased IL-1β expression in non-viable
pregnancies approached, but did not reach the level of significance (p = 0.052) (Fig. 6.6).
At late gestation, trophoblasts from non-viable pregnancies expressed significantly less
IL-4 (p = 0.021), IL-12p35 (p = 0.021), and IL-12p40 (p = 0.038) than trophoblasts from
viable pregnancies (Fig. 6.7).
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Table 6.1
Feline Placental Tissues Included in the Study of Trophoblast
Immunomodulator Expression
Queen number and
placental identification

Pregnancy
term

FIV status

Fetal viability

2779 Placenta B
2779 Placenta D
2779 Placenta E

Early
Early
Early

–
–
–

Viable
Viable
Non-viable; fetal resorption

0326 Placenta A
8035 Placenta B
8035 Placenta C
0866 Placenta A
0866 Placenta B

Early
Early
Early
Early
Early

+
+
+
+
+

Viable
Non-viable; arrested fetus
Non-viable; arrested fetus
Viable
Non-viable; fetal resorption

9581 Placenta A
9581 Placenta B
9746 Placenta C

Late
Late
Late

–
–
–

Viable
Viable
Viable

9730 Placenta B
9730 Resorb 1
9730 Resorb 3
13226 Placenta 3
13226 Placenta 4

Late
Late
Late
Late
Late

+
+
+
+
+

Viable
Non-viable; fetal resorption
Non-viable; fetal resorption
Non-viable; arrested fetus
Non-viable; arrested fetus

Placental tissues were identified based upon the experimental number of the delivering
queen and given an alphabetical or numerical designation based on order of harvest.
Trophoblastic cells were extracted from placental tissues taken from each associated
queen.
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Detection of FIV in Trophoblasts from Early- and Late-Term Feline
Placentas

Real-time RT-PCR analysis of FIV gag gene expression in feline placental trophoblasts
from all pregnancies. (A) early-term placental trophoblastic samples (n = 8); (B) lateterm placental trophoblastic samples (n = 8). Bars represent mean Ct values.
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Figure 6.2

Relative Expression of Immunomodulators in Trophoblasts from
Control Cats

Real-time RT-PCR analysis of normal feline placental trophoblastic expression of the
pro-inflammatory cytokines (IL-6, IL-1β, IL-12p35, and IL-12p40), the antiinflammatory cytokines (IL-4 and IL-5), and the chemokine receptor (CXCR4) in earlyterm uninfected placentas (n = 3) versus late-term uninfected placentas (n = 3). Bars
represent mean Ct values substracted from a negative endpoint (60 - mean Ct), bracketed
by standard errors of the mean. P values obtained from single factor ANOVA and
Wilcoxon rank sum test are noted. Alpha = 0.05.
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Figure 6.3

Relative Expression of Immunomodulators in Trophoblasts from EarlyTerm Feline Placentas

Real-time RT-PCR analysis of feline placental trophoblastic expression of the proinflammatory cytokines (IL-6, IL-1β, IL-12p35, and IL-12p40), the anti-inflammatory
cytokines (IL-4 and IL-5), and the chemokine receptor (CXCR4) in early-term FIVinfected (n = 5) versus uninfected (control) (n = 3) placentas. Bars represent mean Ct
values substracted from a negative endpoint (60 - mean Ct), bracketed by standard errors
of the mean. P values obtained from Wilcoxon rank sum test are noted. Alpha = 0.05.
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Figure 6.4

Relative Expression of Immunomodulators in Trophoblasts from LateTerm Feline Placentas

Real-time RT-PCR analysis of feline placental trophoblastic expression of the proinflammatory cytokines (IL-6, IL-1β, IL-12p35, and IL-12p40), the anti-inflammatory
cytokines (IL-4 and IL-5), and the chemokine receptor (CXCR4) in late-term FIVinfected (n = 5) versus uninfected (control) (n = 3) placentas. Bars represent mean Ct
values substracted from a negative endpoint (60 - mean Ct), bracketed by standard errors
of the mean. P values obtained from Wilcoxon rank sum test are noted. Alpha = 0.05.
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Figure 6.5

Relative Expression of Immunomodulators in Trophoblasts from EarlyTerm FIV-Infected Feline Placentas

Real-time RT-PCR analysis of trophoblastic expression of the pro-inflammatory
cytokines (IL-6, IL-1β, and IL-12p35) and the anti-inflammatory cytokines (IL-4 and
IL-5) in placentas from FIV-infected viable (n = 2) versus FIV-infected non-viable (n =
3) pregnancies. Bars represent mean Ct values substracted from a negative endpoint (60 mean Ct), bracketed by standard errors of the mean. P values obtained from Wilcoxon
rank sum test are noted. Alpha = 0.05.
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Figure 6.6

Relative Expression of Immunomodulators in Trophoblasts from EarlyTerm Feline Placentas from Viable and Non-viable Pregnancies

Real-time RT-PCR analysis of trophoblastic expression of the pro-inflammatory
cytokines (IL-6, IL-1β, IL-12p35, and IL-12p40), the anti-inflammatory cytokines (IL-4
and IL-5), and the chemokine receptor (CXCR4) in early-term placentas from all viable
(n = 4) versus all non-viable (n = 4) pregnancies. Bars represent mean Ct values
substracted from a negative endpoint (60 - mean Ct), bracketed by standard errors of the
mean. P values obtained from Wilcoxon rank sum test are noted. Alpha = 0.05.
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Figure 6.7

Relative Expression of Immunomodulators in Trophoblasts from LateTerm Feline Placentas from Viable and Non-viable Pregnancies

Real-time RT-PCR analysis of trophoblastic expression of the pro-inflammatory
cytokines (IL-6, IL-1β, IL-12p35, and IL-12p40), the anti-inflammatory cytokines (IL-4
and IL-5), and the chemokine receptor (CXCR4) in late-term placentas from all viable
(n = 4) versus all non-viable (n = 4) pregnancies. Bars represent mean Ct values
substracted from a negative endpoint (60 - mean Ct), bracketed by standard errors of the
mean. P values obtained from Wilcoxon rank sum test are noted. Alpha = 0.05.
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Discussion
HIV infection of pregnant women contributes to reproductive failure. Langston et
al. (1995) reported spontaneous fetal death in 14 of 124 (11.3%) HIV-infected
pregnancies during 8 to 32 weeks gestation. In addition, HIV-infected, pregnant women
receiving the highly active antiretroviral therapy (HAART) were more likely to have
complications during pregnancy and poor reproductive outcomes including intrauterine
growth restriction, preterm labor, and low birth weights when compared to HIV-negative
women (Olagbuji et al., 2009).
Similar to HIV, reproductive failure and fetal loss is associated with FIVinfection. Vertical transfer of FIV occurs commonly under experimental conditions
producing some viable offspring among majority non-viable litters (Allison and Hoover,
2003; Boudreaux et al., 2009; Weaver et al., 2005). Using the FIV-infected, pregnant
queen to evaluate compromised reproduction resulting from infection, we reported
vertical transfer of FIV-B-2542 at early- and late-term pregnancy (Boudreaux et al.,
2009; Weaver et al., 2005). In reports by our laboratory (Boudreaux et al., 2009; Weaver
et al., 2005) and others (O'Neil et al., 1996), FIV-B-2542-infected queens transmitted the
virus to more than 50% of their offspring. Boudreaux et al. (2009) reported that fetal
non-viability (defined as fetal resorptions or developmentally-arrested fetuses) at early
gestation was 4.7% (2/43 fetuses) in control cats and 22.2% (6/27 fetuses) in FIVinfected cats. We also reported high rates of fetal non-viability at late gestation (Weaver
et al., 2005). In that report, fetal non-viability was 3.2% (1/31 fetuses) in control cats and
60% (15/25 fetuses) in FIV-infected cats. In addition, higher incidences of fetal non-
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viability associated with acutely-infected versus chronically-infected queens (53% and
30%, respectively) was reported (O'Neil et al., 1995). Therefore, the FIV-infected,
pregnant queen is an acceptable small animal model for the study of lentiviral
transplacental transfer and pregnancy perturbation associated with infection.
The immunology of pregnancy is an inexplicable phenomenon, and the role of
immunoregulatory molecules such as cytokines and chemokines in maintaining immune
homeostatis during pregnancy remains unclear. Wegmann et al. (1993) proposed that
successful pregnancy is biased toward a Th2 (anti-inflammatory) immune response with
a suppressed Th1 (pro-inflammatory) immune response at the maternal-fetal interface.
This hypothesis was validated when spontaneous abortion occurred in pregnant CBA/J x
DBA/2 mice when administered exogenous Th1 cytokines (IL-2, TNF-α, and IFN-γ).
However, spontaneous abortion in pregnant CBA/J x DBA/2 mice was prevented when
mice were administered antibodies against Th1 cytokines or given the exogenous Th2
cytokines (IL-10, GM-CSF, and IL-13) (Chaouat et al., 1995; Clark et al., 1998).
Similarly, women with recurrent spontaneous abortions expressed higher levels of Th1
cytokines, IFN-γ (Daher et al., 2004; Hill et al., 1995; Lim et al., 2000; Marzi et al., 1996;
Raghupathy et al., 1999; Raghupathy et al., 2000), TNF-α (Daher et al., 2004;
Raghupathy et al., 2000), and IL-2 (Hill et al., 1995; Marzi et al., 1996; Raghupathy et
al., 2000) and decreased levels of Th2 cytokines, IL-10 (Hill et al., 1995; Marzi et al.,
1996; Raghupathy et al., 1999; Raghupathy et al., 2000) , IL-6 (Lim et al., 2000;
Raghupathy et al., 1999; Raghupathy et al., 2000), and IL-4 (Hill et al., 1995; Marzi et
al., 1996; Raghupathy et al., 2000) when compared to normal pregnant women.
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Therefore it appears that, like the murine model, normal human pregnancy is biased
towards Th2 cytokine production and that Th1-type immunity is associated with
reproductive failure.
In a previous report by our laboratory (Weaver et al., 2005), we evaluated
expression of representative Th1 cytokines (IL-1β and IFN-γ) and a Th2 cytokine (IL-10)
in late-term placental tissues from FIV-infected and control cats. Although we did not
detect significant differences in the expression of Th1 and Th2 cytokines, there was a
trend towards increased Th1 cytokine expression and decreased Th2 cytokine expression.
Moreover, when cytokine expression was evaluated in placentas from all viable versus all
non-viable pregnancies, there was increased expression of IL-1β and IFN-γ and no
significant difference in the expression of IL-10. However, we were not able to evaluate
early-term placental expression of these cytokines.
In Chapter III of this study, we evaluated the expression of representative proinflammatory cytokines (IL-6, IL-12p35, and IL-1β), the anti-inflammatory cytokine (IL10), and the chemokine (SDF-1α) in early- and late-term placental tissues. We found that
with the exception of IL-12p35, patterns of cytokine expression in control animals were
as we predicted, Th2 cytokine mRNAs (IL-10 and IL-6) were higher at early gestation
and decreased by late gestation, while pro-inflammatory mediator mRNAs (IL-1β and
SDF-1α) were lower at early gestation and increased by late gestation. However, we did
not evaluate the specific cell populations responsible for the production of cytokines and
chemokines during pregnancy.
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In this study, we evaluated feline placental immunopathology associated with
lentiviral infection by studying cytokine expression in trophoblastic cells. By evaluating
cytokine production in trophoblasts, we predicted that we would detect evidence of a proinflammatory microenvironment in the placentas associated with FIV infection and nonviable pregnancies. However, we did not see this pattern. We report expression of IL-4,
IL-5, IL-6, IL-1β, IL-12p35, IL-12p40, and CXCR4 in feline placental trophoblasts at
both time points during feline gestation. Increased expression of pro-inflammatory
cytokines associated with reproductive failure was not evident. The relative expression
of all trophoblastic immunomodulators increased in uninfected cats as gestation
progressed, indicating increased immune function of trophoblasts at late pregnancy. At
early gestation, FIV infection and non-viability was associated with decreased
expression of all cytokines. However, only IL-5 (an anti-inflammatory cytokine) was
significantly decreased in FIV-infected queens at early gestation. In addition, when
immunomodulator expression in early-term placental trophoblasts from all viable
pregnancies were compared to all non-viable pregnancies, non-viability was associated
with significantly decreased expression of the anti-inflammatory cytokine IL-4 and two
pro-inflammatory cytokines (IL-6 and IL-12p35). The low concentrations of IL-4 and
IL-6 in early-term placental trophoblasts parallels the IL-4 and IL-6 expression patterns
found in the endometrial tissue and deciduas of women with frequent implantation
failures (Stewart-Akers et al., 1998) and recurrent abortions (Piccinni and Romagnani,
1996). IL-4 is a Th2 cytokine that is mainly involved in the peri-implantation period of
placental development (Wilczynski, 2005). Together with transforming growth factor-β
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(TGF-β), IL-4 mediates the process of trophoblast invasion during human placentation
(Irving and Lala, 1995; Klentzeris, 1997; Piccinni et al., 2000a; Piccinni et al., 2000b).
Moreover, IL-4 and IL-6 are responsible for the angiogenesis of trophoblastic villi
(Jauniaux et al., 1996). In addition, IL-12 (a pro-inflammatory cytokine produced by
macrophages) can impede the depth of trophoblast invasion by inducing trophoblast
apoptosis (Bennett et al., 1996; Marzusch et al., 1997). Therefore, the decreased
expression of IL-4, IL-6, and IL-12p35 may indicate that trophoblastic infiltration is
hindered during early-term feline gestation, and the resulting lack of oxygen and nutrient
supply from the uterus contributes to fetal non-viability. At late gestation, FIV infection
and non-viability was associated with decreased expression of all cytokines. However,
only IL-4 and IL-12p35 were significantly down-regulated in placental trophoblasts from
infected queens. In addition, when immunomodulator expression in late-term placental
trophoblasts from all viable pregnancies were compared to placental trophoblasts from all
non-viable pregnancies, IL-4, both IL-12 genes, and CXCR4 were depressed. The low
expression of IL-4 and IL-12p35 associated with non-viability parallels the expression of
these immunomodulators at early-term gestation. However, the non-viability at late-term
gestation suggests that the immunoregulatory molecules (IL-4 and IL-12p35) impact fetal
viability, especially at early feline gestation.
We failed to detect the primary receptor for FIV (CD134) in any trophoblastic
sample from early- or late-term pregnancy, and we were able to detect FIV in only one
late-term placental sample from a fetal resorption. Therefore, direct viral infection of
trophoblasts apparently did not affect trophoblast function. Perhaps the altered placental
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microenvironment of the surrounding infected tissue indirectly affects trophoblast
function. To our knowledge, this is the first report describing lentivirus-induced
placental immunomodulation in feline trophoblasts.
Our data do not support the Th1/Th2 paradigm of pregnancy proposal by
Wegmann et al. (1993). We found expression of pro-inflammatory and antiinflammatory cytokines at both time points during feline gestation. We were unable to
associate the production of pro-inflammatory cytokines with the occurrence of
reproductive failure. Others have reported patterns of cytokine expression that also
challenge the paradigm. Bates et al. (2002) reported increased production of IFN-γ and
decreased production of IL-10 and IL-4 in peripheral blood mononuclear cells (PBMCs)
of normal pregnant women when compared to women with recurrent pregnancy loss
(RPL), repudiating the hypothesis that Th1 immunity is associated with fetal loss.
Moreover, in that report, there was no significant difference in the expression of IFN-γ,
IL-10, or IL-4 in women with a history of RPL who subsequently aborted when
compared to RPL women with successful pregnancy outcomes. Interestingly, the
concentrations of TNF-α in PBMCs were similar in RPL women with successful
pregnancy outcomes and normal pregnant women. In addition, RPL women who
subsequently aborted expressed lower concentrations of TNF-α when compared to
normal pregnant women (Bates et al., 2002).
We report a disparity in trophoblastic immunomodulator expression between
placentas from HIV-infected women and the FIV-infected cat. Lee et al. (1997) reported
cultured placental trophoblasts from HIV-infected women expressed significantly higher
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amounts of IL-1β, IL-6, and TNF-α than placentas from uninfected women. These data
indicate that HIV-infection during pregnancy results in increased cytokine expression and
that a pro-inflammatory microenvironment (an environment potentially conducive to
vertical transfer) exists in HIV-infected placentas. However, we did not see this trend in
the animal model. In this report, we demonstrated increased immune function of
trophoblasts late in gestation. However, this cellular population does not appear to
support the replication of FIV. Therefore, there may be other immune cells that
contribute to immunopathology, such as regulatory T cells (Tregs), which were shown to
support the replication of FIV (Joshi et al., 2005; Joshi et al., 2004). Our laboratory is
currently investigating feline Tregs in lentivirus-induced immunopathology and
pregnancy failure.
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CHAPTER VII
SUMMARY

Pediatric AIDS is an integral part of the global HIV/AIDS pandemic. In the
United States, pediatric AIDS cases (defined as AIDS occurring in children under the age
of 13 years) represent 1% of the total number of AIDS cases (CDC, 2005), with motherto-child transmission (MTCT) of the virus accounting for 90% of pediatric infections
(CDC, 2008). Children who are infected in utero have a more rapid progression to AIDS
and generally become symptomatic during the first year of life. In the absence of
antiviral treatment, 50% of HIV-infected newborns will succumb to the disease before 24
months of age (UNAIDS/WHO, 2009). Moreover, transplacental transfer of HIV results
in poor reproductive outcomes, including low birth weight babies, preterm delivery, and
an increased incidence of spontaneous abortions (D'Ubaldo et al., 1998; Kumar et al.,
1995; Langston et al., 1995).
Using the FIV-infected cat as a model for lentiviral transplacental transfer, we
previously demonstrated frequent reproductive failure in litters delivered at early- and
late-term gestation by cesarean section (Boudreaux et al., 2009; Weaver et al., 2005).
Vertical transmission of FIV occurred in all pregnancies and FIV was detected in the
tissues of both viable and non-viable kittens and fetuses. Fetal non-viability was
associated with early pregnancy, and litter size was larger in uninfected cats. In addition,
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increased placental expression of Th1 cytokines was associated with FIV-infected,
resorbed fetuses, suggesting that FIV infection may dysregulate placental cytokines
during late-term gestation and compromise pregnancy (Weaver et al., 2005). However,
neither early-term placental tissue nor the specific placental cell populations responsible
for cytokine production were evaluated. Thus, we hypothesized that FIV infections may
cause dysregulation of placental cytokine expression, probably early in gestation, and
aberrant expression of these cytokines may potentiate inflammation and transplacental
infections.
In Chapter II of this dissertation, we reported the first evidence of the FIV
primary receptor, CD134 at the feline maternal-fetal interface. Expression of CD134 and
the FIV co-receptor, CXCR4 was observed in all late-term placental tissues. The
presence of these receptors may render the placenta vulnerable to FIV infection, possibly
facilitating efficient vertical transmission of FIV, and impact pregnancy outcome. We
found that placentas from FIV-infected queens producing litters of only viable offspring
expressed more CD134 and CXCR4 mRNA than those from uninfected queens,
suggesting that infection may cause upregulation of the receptors. On the other hand,
placentas from FIV-infected cats with non-successful pregnancies expressed similar
levels of CD134 mRNA and slightly less CXCR4 mRNA than those from uninfected
queens. Thus, it appears that cells that express these receptors may play a role in
pregnancy maintenance. A separate study in our laboratory is currently examining
whether regulatory T cells, which express both markers and are preferentially infected by
FIV, may contribute to pregnancy outcome in the FIV-infected cat.
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In Chapter III, we evaluated cytokine dysregulation in placental tissues from
early- and late-term pregnancy. We quantified the expression of representative proinflammatory cytokines (IL-6, IL-12p35, and IL-1β), the anti-inflammatory cytokine IL10, and the chemokine SDF-1α in early- and late-term placental tissues and evaluated
whether immunomodulator expression was related to fetal FIV infection. With the
exception of IL-12p35, patterns of cytokine expression in control animals were as we
predicted, Th2 cytokine mRNAs (IL-10 and IL-6) were higher at early gestation and
decreased by late gestation, while pro-inflammatory mediator mRNAs (IL-1β and SDF1α) were lower at early gestation and increased by late gestation. We report that FIVinfection during early gestation was associated with increased expression of two proinflammatory cytokines, IL-6 and IL-12p35, and decreased expression of IL-10,
supporting the idea that a virus-induced inflammatory microenvironment occurred at
early pregnancy. At late gestation, IL-6 expression was significantly increased while IL1β and SDF-1α were decreased. Only IL-6 placental expression was consistently affected
by viral infection, increasing in FIV-infected cats at both gestational stages. IL-6 is a
multi-functional cytokine produced by both immune cells and trophoblasts that promotes
HCG production in early human pregnancy. However, the function of IL-6 in feline
gestation is unknown. Placentas from non-viable fetuses produced significantly
decreased SDF-1α and IL-12p35, but no other differences in cytokine expression were
detected. SDF-1α is the chemokine ligand for CXCR4. The decreased expression in
non-viable pregnancies correlate with decreased CXCR4 expression in the same cats
discussed above. While the impact that these immunopathological findings may have on
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fetal infection and reproductive failure are not yet known, we found that FIV infection
clearly alters the placental cytokine microenvironment.
In Chapter IV, we report a novel feline placental immunohistochemistry method
for specifically targeting feline cytokeratin antigens and selectively labeling placental
trophoblasts. We found that like human placental tissue, the feline placenta presents a
unique challenge to the use of immunolabeling for detection of placental antigens.
Similar to immunohistochemistry studies involving human placental tissue, we
encountered problems with non-specific immunoreactivity using traditional IHC
methods. After we determined that immunoreactivity could not be eliminated with
altered blocking methods, we developed an innovative immunohistochemistry procedure
utilizing a wide spectrum rabbit polyclonal antibody and goat anti-rabbit secondary
polyclonal antibody to label cytokeratin specifically in feline trophoblasts and eliminate
non-specific binding. Specifically labeling placental trophoblasts was necessary for us to
determine the role of trophoblasts in FIV-induced placental immunopathology.
In order to continue our evaluation of feline trophoblasts and their role in FIVinduced immunopathology, in Chapter V we evaluated the integrity of frozen feline
placental tissues using hematoxylin and eosin (H&E) staining. We found that
hematoxylin and eosin staining of FIV-B-2542-infected and uninfected samples resulted
in stained cells with blue nuclei and pink cytoplasm and confirmed that tissue integrity
was not compromised during frozen storage. We also identified and collected placental
trophoblasts from early- and late-term FIV-infected and uninfected queens using our
novel IHC procedure and laser capture microdissection.
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In Chapter VI, we reported the first evidence of placental immunomodulator
expression in feline trophoblasts. We evaluated cytokine dysregulation in placental cells
known to produce cytokines and chemokines that modulate pregnancy, the trophoblasts.
We suspected that FIV infections may cause dysregulation of trophoblastic cytokine
expression at early- and late-term pregnancy, and aberrant expression of these cytokines
may potentiate inflammation and transplacental infections. We quantified the expression
of Th1 cytokines (TNF-α, IFN-γ, IL-1β, IL-2, IL-12p35, IL-12p40, and IL-18), the Th2
cytokines (IL-4, IL-5, IL-6, and IL-10), the cytokine GM-CSF, the primary FIV receptor
CD134, the chemokine SDF-1α, the chemokine receptor CXCR4, and FIV gag in
trophoblasts from early- and late-term pregnancy. We were able to detect only IL-4, IL5, IL-6, IL-1β, IL-12p35, IL-12p40, and CXCR4 in feline placental trophoblasts from
early- and late-term pregnancy. We found expression of these pro-inflammatory and
anti-inflammatory cytokines at both time points during feline gestation. We report
increased immune function of trophoblasts late in gestation. Only IL-5 (a Th2 cytokine)
expression was altered (decreased) in FIV-infected queens at early gestation. However,
when immunomodulator expression at early gestation was compared for all viable
pregnancies versus all non-viable pregnancies (including both control and infected
animals), IL-4 (a Th2 cytokine), IL-6 (a pleiotropic, multi-functional cytokine), and IL12p35 (a pro-inflammatory cytokine) were all down-regulated. At late gestation, IL-4
and IL-12p35 were down-regulated in placentas from infected queens, and when all
viable and all non-viable pregnancies were compared at this stage, IL-4, both IL-12
genes, and CXCR4 were depressed. While we did not find that increased expression of
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pro-inflammatory cytokines accompanied reproductive failure as we had predicted, FIV
infection did alter expression of some cytokines in trophoblasts, and reproductive failure
was accompanied by down-regulation of both pro- and anti-inflammatory cytokines.
Interestingly, FIV gag was detected in only one trophoblast specimen, and CD134 was
not detected. Thus, feline trophoblasts do not appear to be easily infected by FIV.
Therefore, it is likely that altered immune or physiological function within the
surrounding placental microenvironment influence trophoblast function, rather than direct
viral infection of these cells.
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APPENDIX A
FELINE-SPECIFIC PRIMER DESIGN FOR THE QUANTIFICATION OF CYTOKINE
mRNA IN FELINE TROPHOBLASTS
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Abstract
We used the FIV-infected cat to model HIV-induced placental immunopathology,
detecting increased inflammatory cytokine expression from resorbed fetal tissue. We
hypothesize that FIV dysregulates cytokine expression in trophoblasts, potentiating
inflammation and in utero infections. The purpose of this project was to design felinespecific primers that span intron-exon junctions to target mRNA of placental
immunomodulators. The mRNA sequences for the cat and comparative mammals were
obtained from the National Center for Biotechnology Information (NCBI) and aligned
using the European Bioinformatics Institute (EBI) ClustalW alignment tool. Human
mRNA was blasted against the human genome to find exons, which were used to identify
homologous exons in the feline sequence. Feline mRNA sequences were loaded into
Beacon Designer, and primer/probe sets were selected in which one of the primers
spanned the junction. We evaluated the linear regressions and amplification efficiencies
of each duplex partner using standard curves generated from real-time RT-PCR. We
found variations between the standard curve slope values for β-actin and the target genes,
an unexpected result and an indicator of non-optimal amplification efficiency. However,
all R2 values were close to 1.0, suggesting that our dilution of template was an accurate
predictor of the cycle threshold value. Therefore, the designed primer/probe sets are
optimized to quantify feline placental cytokine mRNA.
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Introduction
The feline immunodeficiency virus (FIV)-infected cat is a well accepted animal
model to study HIV-induced placental immunopathology. Maternal-fetal transmission of
FIV readily occurs under experimental conditions, resulting in infected viable kittens and
resorbed or arrested fetal tissues (Allison and Hoover, 2003; Boudreaux et al., 2009;
O'Neil et al., 1996; Weaver et al., 2005). In a previous report by our lab (Weaver et al.,
2005), increased inflammatory cytokine expression was associated with resorbed fetal
tissue. We hypothesize that FIV dysregulates cytokine expression in placental tissue,
potentiating inflammation and in utero infections. The purpose of this project was to
design feline-specific primers that span intron-exon junctions to target mRNA of
placental immunomodulators.

Materials and Methods

Primer design of immunomodulators and receptors
Representative pro-inflammatory and anti-inflammatory cytokines and
chemokines involved in the maintenance of pregnancy, the receptors for FIV, and the
internal control gene were selected for primer design. Cytokine mRNA sequences for the
cat and other comparative mammals (human, dog, cow, and pig) were obtained from the
National Center for Biotechnology Information (NCBI) and aligned using the European
Molecular Biology Laboratory-European Bioinformatics Institute (EMBL-EBI) ClustalW
alignment tool. The human mRNA was blast-searched against the human genome to
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locate the exon/intron boundaries. These boundaries were used to find the homologous
boundaries in the feline sequence. Beacon Designer (PREMIER Biosoft) was used to
design primer/probe sets targeting the representative pro-inflammatory cytokines (IL-1β,
IL-12p35, and IL-12p40), Th2 cytokines (IL-6 and IL-10), the chemokine (SDF-1α), the
chemokine receptor and FIV co-receptor (CXCR4), the co-stimulatory molecule and FIV
primary receptor (CD134), and the internal control gene (β-actin). All PCR amplicons
spanned intron-exon junctions. The target probes were 5’ labeled with the reporter dye
FAM (6-carboxyfluorescein) and 3’ labeled with the quencher dye TAMRA (6carboxytetramethylrhodamine). The probe for the housekeeping gene was 5’ labeled
with the reporter dye HEX (hexachloro-6-carboxyfluorescein) and 3’ labeled with the
quencher dye TAMRA. The best primer/probe set for each gene of interest was chosen
based upon primer length, melting temperature, and GC content. Primers chosen were
between 9–40 bases in length, had melting temperatures (Tm) between 58–60°C, and a
GC content of 40–80%. Probes selected were between 9–40 bases in length, had melting
temperatures that were 10°C higher than the primer Tm, and a GC content of 20–80%.
All amplicons were between 50–150 bp in length. Primers and probes were obtained
commercially (MWG-BIOTECH, Inc., High Point, NC).

Reference primer and probe sets
Primer/probe sets for IL-2 (Taglinger et al., 2008), IL-4 (Taglinger et al., 2008),
IL-5 (Taglinger et al., 2008), IL-18 (Foley et al., 2003), IFN-γ (Leutenegger et al., 1999),
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GM-CSF (Kipar et al., 2006), TNF-α (Kipar et al., 2001), and FIV gag (Weaver et al.,
2005) were obtained commercially (MWG-BIOTECH, Inc., High Point, NC).

Generation of standard curves
Real-time reverse transcriptase-PCR (rtRT-PCR) targeting β-actin and feline
genes in placental RNA was done using an iCycler (BioRad Laboratories, Valencia, CA)
according to established parameters (Scott et al., 2008). To determine the linear range
and amplification efficiencies of the targeted genes, pooled placental RNA from all earlyand late-term uninfected cats (described in Chapter III) was serially diluted and amplified
in triplicate reactions. The resulting cycle threshold (Ct) values for each two-fold
dilution were used to generate standard curves for each duplex-partner amplicon and the
linear regression was calculated. Standard curves for FIV gag were previously generated
(Boudreaux et al., 2009; Weaver et al., 2005).

Results

Feline-specific primer design
Feline placental immunomodulator-specific primers that spanned intron-exon
junctions were successfully designed. Designed primer and probe sets are listed in Table
A.1. Reference primer and probe sets are listed in Table A.2.
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Linear regressions and amplification efficiencies of β-actin and feline cytokine cDNA
Standard curves generated to determine the linear regressions (R2 values) and
amplification efficiencies (slopes) of each duplex partner are shown in Figures A.1–A.4.
All R2 values and slopes for each target gene are listed in Tables A.3–A.6. Variation
between the standard curve slope values for β-actin and the target genes indicated nonoptimal amplification efficiencies. However, all R2 values were close to 1.0, suggesting
that all points on the standard curve were in a straight line and that our dilution of
template was an accurate predictor of the cycle threshold value. In other words, the
standard curves show that as template was diluted, higher Ct values were generated. This
result indicates that our designed primer/probe sets were efficiently optimized to quantify
placental cytokine mRNA.
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Figure A.1

Standard Curves Generated Using Designed Primer/Probe Sets for the
Quantification of Feline Placental Cytokine mRNA from Early Gestation
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Figure A.2

Standard Curves Generated Using Reference Primer/Probe Sets for the
Quantification of Feline Placental Cytokine mRNA from Early Gestation
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Figure A.3

Standard Curves Generated Using Designed Primer/Probe Sets for the
Quantification of Feline Placental Cytokine mRNA from Late Gestation
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Figure A.4

Standard Curves Generated Using Reference Primer/Probe Sets for the
Quantification of Feline Placental Cytokine mRNA from Late Gestation
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Discussion
FIV may dysregulate placental immunology during pregnancy, potentiating
inflammation and transplacental infections. Evaluating the expression of
immunomodulators in placental tissue is thereby an effective method to determine the
presence of an inflammatory microenvironment in the placenta. In this study, we
designed feline-specific primers that targeted the mRNA of immunomodulators involved
in the maintenance of pregnancy. We evaluated the linear regressions and amplification
efficiencies of each duplex partner using standard curves generated from real-time RTPCR. We found variations between the standard curve slope values for β-actin and the
target genes which is normally a predictor of non-optimal amplification efficiency. Other
investigators have reported optimal amplification efficiencies from similar slope values
for feline cytokine genes and the internal control mRNA (Kipar et al., 2001). Although
we do not have an explanation for the variation of slope values between β-actin and the
target genes, all R2 values were close to 1.0, suggesting that our dilution of template was
an accurate predictor of the cycle threshold value. Therefore, we conclude that all
primer/probe sets amplified the cDNA of the feline immunomodulators and are
efficiently optimized for use in the quantification of placental cytokine mRNA. These
primer/probe sets were used in quantitative PCR for the measurement of cytokine mRNA
in feline placental trophoblasts.
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